Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 553 articles:
HTML format
Text format



Single Articles


    May 2017
  1. DA COSTA A, Guichard JB, Romeyer-Bouchard C
    Reply to the letter to Editor "Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?"
    Int J Cardiol. 2017;235:202.
    PubMed     Text format    


  2. LIANG J, Cha Y
    Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?
    Int J Cardiol. 2017;235:201.
    PubMed     Text format    


  3. CHEN S, Zhou G, Liu S
    Pulmonary vein isolation only may not enough for persistent atrial fibrillation.
    Int J Cardiol. 2017;234:123.
    PubMed     Text format    


  4. KOZA Y, Karakelleoglu S
    Are single nucleotide polymorphisms sufficient to explain recurrence of atrial fibrillation after catheter ablation?
    Int J Cardiol. 2017;234:122.
    PubMed     Text format    


    April 2017
  5. BARKAS F, Elisaf M, Korantzopoulos P, Tsiara S, et al
    The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.
    Int J Cardiol. 2017 Apr 20. pii: S0167-5273(17)31069.
    PubMed     Text format     Abstract available


  6. BAYKANER T, Zografos TA, Zaman JAB, Pantos I, et al
    Spatial relationship of organized rotational and focal sources in human atrial fibrillation to autonomic ganglionated plexi.
    Int J Cardiol. 2017 Apr 19. pii: S0167-5273(17)30158.
    PubMed     Text format     Abstract available


  7. QIU J, Tu T, Zhou S, Liu Q, et al
    Disordered myocardium energy metabolism in the progression of atrial fibrillation in highly trained endurance athletes.
    Int J Cardiol. 2017;233:95.
    PubMed     Text format    


  8. LU Z, He B, Jiang H
    Increasing interest in ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2017;233:104.
    PubMed     Text format    


  9. YANG Y, Liu Q, Liu Z, Zhou S, et al
    Insight of ventricular arrhythmias originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2017;233:103.
    PubMed     Text format    


  10. SPITZER SG, Leitz P, Langbein A, Karolyi L, et al
    Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34442.
    PubMed     Text format     Abstract available


  11. YAMASAKI H, Lustgarten D, Cerkvenik J, Birnie D, et al
    Adaptive CRT in patients with normal AV conduction and left bundle branch block: Does QRS duration matter?
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)33104.
    PubMed     Text format     Abstract available


  12. MURA M, Mehta A, Ramachandra CJ, Zappatore R, et al
    The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Int J Cardiol. 2017 Apr 12. pii: S0167-5273(17)30298.
    PubMed     Text format     Abstract available


  13. ANSELMINO M, Garberoglio L, Gili S, Bertaglia E, et al
    Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
    Int J Cardiol. 2017 Apr 8. pii: S0167-5273(16)32868.
    PubMed     Text format     Abstract available


  14. ARENAS DE LARRIVA AP, Norby FL, Chen LY, Soliman EZ, et al
    Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Int J Cardiol. 2017 Apr 6. pii: S0167-5273(16)34419.
    PubMed     Text format     Abstract available


  15. MERY B, Guichard JB, Guy JB, Vallard A, et al
    Atrial fibrillation in cancer patients: Hindsight, insight and foresight.
    Int J Cardiol. 2017 Apr 5. pii: S0167-5273(17)30307.
    PubMed     Text format     Abstract available


    March 2017
  16. KIM IS, Sohn J, Lee SJ, Park JK, et al
    Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable cardioverter defibrillators: Vulnerable patients to air pollution.
    Int J Cardiol. 2017 Mar 30. pii: S0167-5273(17)30052.
    PubMed     Text format     Abstract available


  17. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Text format     Abstract available


  18. BRUNETTI ND, De Gennaro L, Caldarola P, Gaglione A, et al
    Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?
    Int J Cardiol. 2017 Mar 22. pii: S0167-5273(17)31385.
    PubMed     Text format    


  19. FEMIA G, Sy RW, Puranik R
    Systematic review: Impact of the new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2017 Mar 19. pii: S0167-5273(17)30613.
    PubMed     Text format     Abstract available


  20. CAPPATO R, Ali H
    Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Int J Cardiol. 2017 Mar 18. pii: S0167-5273(17)31691.
    PubMed     Text format     Abstract available


  21. CAMM AJ
    Hopes and disappointments with antiarrhythmic drugs.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(17)31664.
    PubMed     Text format     Abstract available


  22. TOPAZ G, Flint N, Steinvil A, Finkelstein A, et al
    Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Int J Cardiol. 2017 Mar 16. pii: S0167-5273(16)32197.
    PubMed     Text format     Abstract available


  23. GRAY B, Ingles J, Medi C, Driscoll T, et al
    Cardiovascular Effects of Energy Drinks in Familial Long QT Syndrome: A Randomized Cross-Over Study.
    Int J Cardiol. 2017;231:150-154.
    PubMed     Text format     Abstract available


  24. MAKOWSKI M, Smorag I, Makowska J, Bissinger A, et al
    Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.
    Int J Cardiol. 2017 Mar 9. pii: S0167-5273(17)31518.
    PubMed     Text format     Abstract available


    February 2017
  25. FROMMEYER G, Sterneberg M, Dechering DG, Ellermann C, et al
    Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(16)33712.
    PubMed     Text format     Abstract available


  26. PROIETTI M, Lip GY
    Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
    Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
    PubMed     Text format     Abstract available


  27. HU WS, Lin CL
    CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31127.
    PubMed     Text format     Abstract available


  28. JORGENSEN TH, Thyregod HG, Tarp JB, Svendsen JH, et al
    Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Int J Cardiol. 2017 Feb 24. pii: S0167-5273(17)31128.
    PubMed     Text format     Abstract available


  29. ANSELMINO M, Matta M, Bunch TJ, Fiala M, et al
    Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(16)33338.
    PubMed     Text format     Abstract available


  30. CENSI F, Calcagnini G, Mattei E, Calo L, et al
    Seasonal trends in atrial fibrillation episodes and physical activity collected daily with a remote monitoring system for cardiac implantable electronic devices.
    Int J Cardiol. 2017 Feb 22. pii: S0167-5273(17)31103.
    PubMed     Text format     Abstract available


  31. TZIKAS A, Freixa X, Llull L, Gafoor S, et al
    Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)33705.
    PubMed     Text format     Abstract available


  32. LEE SR, Choi EK, Han KD, Cha MJ, et al
    Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
    Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
    PubMed     Text format     Abstract available


  33. BADENCO N, Chong-Nguyen C, Maupain C, Himbert C, et al
    Respective role of surface electrocardiogram and His bundle recordings to assess the risk of atrioventricular block after transcatheter aortic valve replacement.
    Int J Cardiol. 2017 Feb 10. pii: S0167-5273(16)32853.
    PubMed     Text format     Abstract available


  34. MENDEZ-BAILON M, Lopez-de-Andres A, de Miguel-Diez J, de Miguel-Yanes JM, et al
    Chronic obstructive pulmonary disease predicts higher incidence and in hospital mortality for atrial fibrillation. An observational study using hospital discharge data in Spain (2004-2013).
    Int J Cardiol. 2017 Feb 7. pii: S0167-5273(16)34024.
    PubMed     Text format     Abstract available


  35. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
    Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
    Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
    PubMed     Text format     Abstract available


    January 2017
  36. SWISSA M, Birk E, Dagan T, Naimer SA, et al
    Radiofrequency catheter ablation of atrioventricular node reentrant tachycardia in children with limited fluoroscopy.
    Int J Cardiol. 2017 Jan 31. pii: S0167-5273(16)34000.
    PubMed     Text format     Abstract available


  37. LIEVE KV, Verkerk AO, Podliesna S, van der Werf C, et al
    Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.
    Int J Cardiol. 2017 Jan 29. pii: S0167-5273(16)33462.
    PubMed     Text format     Abstract available


  38. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Corrigendum to 'Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology' [Int. J. Cardiol. 220 (2016) 131-136].
    Int J Cardiol. 2017 Jan 27. pii: S0167-5273(17)30190.
    PubMed     Text format    


  39. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available


  40. FROMMEYER G, Kohnke A, Ellermann C, Dechering DG, et al
    Acute infusion of levosimendan enhances atrial fibrillation in an experimental whole-heart model.
    Int J Cardiol. 2017 Jan 18. pii: S0167-5273(16)34672.
    PubMed     Text format     Abstract available


  41. LIAO YC, Chung FP, Lin YJ, Chang SL, et al
    The application of signal average ECG in the prediction of recurrences after catheter ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Int J Cardiol. 2017 Jan 18. pii: S0167-5273(16)33160.
    PubMed     Text format     Abstract available


  42. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available


  43. SOLARI D, Bertero E, Miceli R, Brunelli C, et al
    Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
    Int J Cardiol. 2017 Jan 14. pii: S0167-5273(16)33968.
    PubMed     Text format     Abstract available


  44. MCLELLAN AJ, Kumar S, Smith C, Ling LH, et al
    The role of adenosine challenge in catheter ablation for atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2017 Jan 8. pii: S0167-5273(16)33903.
    PubMed     Text format     Abstract available


  45. DODD KW, Elm KD, Dodd EM, Smith SW, et al
    Among patients with left bundle branch block, T-wave peak to T-wave end time is prolonged in the presence of acute coronary occlusion.
    Int J Cardiol. 2017 Jan 7. pii: S0167-5273(16)32444.
    PubMed     Text format     Abstract available


  46. HANON O, Vidal JS, Le Heuzey JY, Kirchhof P, et al
    Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.
    Int J Cardiol. 2017 Jan 7. pii: S0167-5273(17)30078.
    PubMed     Text format     Abstract available


  47. MESQUITA J, Cavaco D, Ferreira A, Lopes N, et al
    Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30065.
    PubMed     Text format     Abstract available


  48. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(17)30072.
    PubMed     Text format     Abstract available


  49. FENG Y, Liu J, Wang M, Liu M, et al
    The E23K variant of the Kir6.2 subunit of the ATP-sensitive potassium channel increases susceptibility to ventricular arrhythmia in response to ischemia in rats.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(17)30041.
    PubMed     Text format     Abstract available


  50. MAURIZI N, Tanini I, Olivotto I, Amendola E, et al
    Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(16)33706.
    PubMed     Text format     Abstract available


  51. BASILI S, Loffredo L, Pastori D, Proietti M, et al
    Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study.
    Int J Cardiol. 2017 Jan 4. pii: S0167-5273(16)33242.
    PubMed     Text format     Abstract available


    December 2016
  52. YOUNES A, Al-Kindi SG, Alajaji W, Mackall JA, et al
    Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)32654.
    PubMed     Text format     Abstract available


  53. NEEFS J, van den Berg NW, Limpens J, Berger WR, et al
    Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Int J Cardiol. 2016 Dec 23. pii: S0167-5273(16)32577.
    PubMed     Text format     Abstract available


  54. GOUDIS CA, Ketikoglou DG
    Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications.
    Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34611.
    PubMed     Text format     Abstract available


  55. SIMANTIRAKIS EN, Papakonstantinou PE, Chlouverakis GI, Kanoupakis EM, et al
    Asymptomatic versus symptomatic episodes in patients with paroxysmal atrial fibrillation via long-term monitoring with implantable loop recorders.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)33814.
    PubMed     Text format     Abstract available


  56. YANG PS, Kim TH, Uhm JS, Kim JY, et al
    Clinical characteristics of complex aortic plaque in patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34564.
    PubMed     Text format     Abstract available


  57. LIU JC, Wang TJ, Sung LC, Kao PF, et al
    Influenza vaccination reduces hemorrhagic stroke risk in patients with atrial fibrillation: A population-based cohort study.
    Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34563.
    PubMed     Text format     Abstract available


  58. SAFAK E, D'Ancona G, Ince H
    Reply to "Don't throw the baby out with the bathwater: Appropriate or inappropriate shocks after implantable cardioverter-defibrillator".
    Int J Cardiol. 2016 Dec 13. pii: S0167-5273(16)34256.
    PubMed     Text format    


  59. DUYGU H
    Galectin-3 and atrial fibrillation.
    Int J Cardiol. 2016 Dec 8. pii: S0167-5273(16)33915.
    PubMed     Text format    


  60. SVERDLOV AL, Ngo DT
    Response to the letter to editor: Galectin-3 and atrial fibrillation.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34243.
    PubMed     Text format    


  61. CERIT L
    Prediction of thromboembolic events for patients with non-valvular atrial fibrillation; CHA2DS2-VASc-UA2-VitD.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34060.
    PubMed     Text format    


  62. HE H, Guo J
    Response to the letter to editor: Prediction of thromboembolic events for patients with non-valvular atrial fibrillation CHA2DS2-VASc-UA2-VitD.
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34248.
    PubMed     Text format    


  63. LI N, Dobrev D
    Hyperuricemia: A causal player or a bystander linking inflammatory signaling and atrial fibrillation?
    Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)34221.
    PubMed     Text format    


  64. ANDO G, Capranzano P
    Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis.
    Int J Cardiol. 2016 Dec 2. pii: S0167-5273(16)32808.
    PubMed     Text format     Abstract available


    November 2016
  65. LOU B, Gao H, Zhou C
    Remote ischemic preconditioning reduces the recurrence of atrial fibrillation after ablation: Essentially influential factors need to be adjusted.
    Int J Cardiol. 2016 Nov 19. pii: S0167-5273(16)33536.
    PubMed     Text format    


  66. LEE CH, Lin TY, Chang SH, Chen CH, et al
    Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Int J Cardiol. 2016;228:771-778.
    PubMed     Text format     Abstract available


  67. JACOB KA, Buijsrogge MP, Frencken JF, Ten Berg MJ, et al
    White blood cell count and new-onset atrial fibrillation after cardiac surgery.
    Int J Cardiol. 2016;228:971-976.
    PubMed     Text format     Abstract available


  68. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Text format     Abstract available


  69. LIU T, Shao Q, Korantzopoulos P, Miao S, et al
    Relation of red blood cell distribution width with CHADS2 and CHA2DS2-VASc score in Chinese patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016;228:861-864.
    PubMed     Text format     Abstract available


  70. KOSIUK J, Hilbert S, John S, Bertagnolli L, et al
    Preliminary experience with high-density electroanatomical mapping for ablation of atrial fibrillation - Comparison of mini-basket and novel open irrigated magnetic ablation catheter in consecutive patients.
    Int J Cardiol. 2016;228:401-405.
    PubMed     Text format     Abstract available


  71. TAKAOKA H, Funabashi N, Ozawa K, Uehara M, et al
    Computed tomography is important in appropriately diagnosing patients with third-degree atrioventricular block and second-degree atrioventricular block but not Wenckebach type.
    Int J Cardiol. 2016;228:700-706.
    PubMed     Text format     Abstract available


  72. CAPUTO ML, Regoli F, Conte G, Adjibodou B, et al
    Temporal trends and long term follow-up of implantable cardioverter defibrillator therapy for secondary prevention: A 15-year single-centre experience.
    Int J Cardiol. 2016;228:31-36.
    PubMed     Text format     Abstract available


  73. DE SOUZA MV, de Fatima Dos Santos Teixeira P, Vaisman M, Xavier SS, et al
    Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation.
    Int J Cardiol. 2016;228:919-925.
    PubMed     Text format     Abstract available


  74. CHOU RH, Lo LW, Liou YJ, Shu JH, et al
    Antipsychotic treatment is associated with risk of atrial fibrillation: A nationwide nested case-control study.
    Int J Cardiol. 2016;227:134-140.
    PubMed     Text format     Abstract available


  75. RUSSELL EA, Walsh WF, Tran L, Tam R, et al
    The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients.
    Int J Cardiol. 2016;227:100-105.
    PubMed     Text format     Abstract available


  76. LEIBOWITZ D, Abitbol C, Alcalai R, Rivkin G, et al
    Perioperative atrial fibrillation is associated with increased one-year mortality in elderly patients after repair of hip fracture.
    Int J Cardiol. 2016;227:58-60.
    PubMed     Text format     Abstract available


  77. NISHIYAMA T, Tanosaki S, Tanaka M, Yanagisawa R, et al
    Predictive factor and clinical consequence of left bundle-branch block after a transcatheter aortic valve implantation.
    Int J Cardiol. 2016;227:25-29.
    PubMed     Text format     Abstract available


  78. ZHAO LQ, Zhang GB, Wen ZJ, Huang CK, et al
    Common variants predict recurrence after nonfamilial atrial fibrillation ablation in Chinese Han population.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33504.
    PubMed     Text format     Abstract available


  79. WANG YS, Chen GY, Li XH, Zhou X, et al
    Prolonged P-wave duration is associated with atrial fibrillation recurrence after radiofrequency catheter ablation: A systematic review and meta-analysis.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33500.
    PubMed     Text format     Abstract available


  80. GUERRA F, Romandini A, Barbarossa A, Belardinelli L, et al
    Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33562.
    PubMed     Text format     Abstract available


  81. ZHU W, Fu L, Ding Y, Huang L, et al
    Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
    PubMed     Text format     Abstract available


  82. TAKIGAWA M, Takahashi A, Kuwahara T, Okubo K, et al
    Long-term outcome after catheter ablation of paroxysmal atrial fibrillation: Impact of different atrial fibrillation foci.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33474.
    PubMed     Text format     Abstract available


  83. PAPAGEORGIOU N, Providencia R, Srinivasan N, Bronis K, et al
    Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.
    Int J Cardiol. 2016;227:151-160.
    PubMed     Text format     Abstract available


  84. PHILLIPS KP, Walker DT
    Long term outcomes from catheter ablation of very longstanding persistent atrial fibrillation.
    Int J Cardiol. 2016;228:865-869.
    PubMed     Text format     Abstract available


  85. WU SH, Qin M, Jiang WF, Wang YL, et al
    A clinical study on the electrophysiological characteristics of patients without recurrence after ablation of persistent atrial fibrillation.
    Int J Cardiol. 2016;228:853-860.
    PubMed     Text format     Abstract available


  86. PONTONE G, Andreini D, Petulla M, Annoni A, et al
    Left atrium and pulmonary vein imaging using sub-millisiviert cardiac computed tomography: Impact on radiofrequency catheter ablation cumulative radiation exposure and outcome in atrial fibrillation patients.
    Int J Cardiol. 2016;228:805-811.
    PubMed     Text format     Abstract available


  87. NAKAMURA K, Naito S, Kaseno K, Nakatani Y, et al
    Integration of intracardiac echocardiography and computed tomography during atrial fibrillation ablation: Combining ultrasound contours obtained from the right atrium and ventricular outflow tract.
    Int J Cardiol. 2016;228:677-686.
    PubMed     Text format     Abstract available


  88. LIN CY, Chung FP, Lin YJ, Chang SL, et al
    Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33499.
    PubMed     Text format     Abstract available


  89. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
    Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
    PubMed     Text format     Abstract available


  90. YANG CH, Chou CC, Hung KC, Wen MS, et al
    Comparisons of the underlying mechanisms of left atrial remodeling after repeat circumferential pulmonary vein isolation with or without additional left atrial linear ablation in patients with recurrent atrial fibrillation.
    Int J Cardiol. 2016;228:449-455.
    PubMed     Text format     Abstract available


  91. HONARBAKHSH S, Providencia R, Srinivasan N, Ahsan S, et al
    A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.
    Int J Cardiol. 2016;228:280-285.
    PubMed     Text format     Abstract available


  92. FROMMEYER G, Puckhaber D, Ellermann C, Dechering DG, et al
    Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone.
    Int J Cardiol. 2016;228:74-79.
    PubMed     Text format     Abstract available


  93. WITKOWSKI M, Bissinger A, Grycewicz T, Lubinski A, et al
    Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker.
    Int J Cardiol. 2016 Nov 5. pii: S0167-5273(16)33302.
    PubMed     Text format     Abstract available


  94. ALLAMSETTY S, Lo LW, Lin YJ, Chang SL, et al
    Impact of aortic encroachment to left atrium on non-pulmonary vein triggers of atrial fibrillation.
    Int J Cardiol. 2016 Nov 1. pii: S0167-5273(16)33269.
    PubMed     Text format     Abstract available


    October 2016
  95. SANCHIS-GOMAR F, Perez-Quilis C, Lippi G, Cervellin G, et al
    Atrial fibrillation in highly trained endurance athletes - Description of a syndrome.
    Int J Cardiol. 2016;226:11-20.
    PubMed     Text format     Abstract available


  96. CERIT L
    Don't throw the baby out with the bathwater: Appropriate or inappropriate shocks after implantable cardioverter-defibrillator.
    Int J Cardiol. 2016 Oct 13. pii: S0167-5273(16)32388.
    PubMed     Text format    


  97. MARTINEZ-ALANIS M, Ruiz-Velasco S, Lerma C
    Quantitative analysis of ventricular ectopic beats in short-term RR interval recordings to predict imminent ventricular tachyarrhythmia.
    Int J Cardiol. 2016;225:226-233.
    PubMed     Text format     Abstract available


  98. ZHAO L, Xu K, Jiang W, Zhou L, et al
    Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement.
    Int J Cardiol. 2016;225:82-86.
    PubMed     Text format     Abstract available


  99. ANDO G, Trio O
    New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation.
    Int J Cardiol. 2016;225:244-246.
    PubMed     Text format    


    September 2016
  100. VAN DEN BERG NW, Slieker MG, van Beynum IM, Bilardo CM, et al
    Fluorinated steroids do not improve outcome of isolated atrioventricular block.
    Int J Cardiol. 2016;225:167-171.
    PubMed     Text format     Abstract available


  101. BROWN LA, Boos CJ
    Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Int J Cardiol. 2016 Sep 30. pii: S0167-5273(16)32512.
    PubMed     Text format     Abstract available


  102. MARZONA I, Vannini T, Roncaglioni MC, Tettamanti M, et al
    Response to " Dementia and death: Separate sides of the same Atrial Fibrillation coin?"
    Int J Cardiol. 2016 Sep 28. pii: S0167-5273(16)32566.
    PubMed     Text format    


  103. CHANG Q, Liu R
    Atrioventricular dissociation with QRS complex change in the atrioventricular block: What are the degree and the site of block?
    Int J Cardiol. 2016;225:215-217.
    PubMed     Text format    


  104. BADHWAR N, Mittal S, Rasekh A, Vasaiwala S, et al
    Conversion of persistent atrial fibrillation to sinus rhythm after LAA ligation with the LARIAT device.
    Int J Cardiol. 2016;225:120-122.
    PubMed     Text format    


  105. GARG L, Garg J, Gupta N, Shah N, et al
    Gastrointestinal complications associated with catheter ablation for atrial fibrillation.
    Int J Cardiol. 2016;224:424-430.
    PubMed     Text format     Abstract available


  106. KIUCHI MG, Chen S
    Renal sympathetic stimulation in patients with controlled hypertension and paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;224:394-397.
    PubMed     Text format    


  107. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
    Int J Cardiol. 2016;225:30-36.
    PubMed     Text format     Abstract available


  108. CHUGH Y, Faillace RT
    The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
    Int J Cardiol. 2016;224:431-436.
    PubMed     Text format     Abstract available


  109. WONGCHAROEN W, Ruttanaphol A, Gunaparn S, Phrommintikul A, et al
    Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;224:252-255.
    PubMed     Text format     Abstract available


  110. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
    A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
    Int J Cardiol. 2016;224:454-455.
    PubMed     Text format    


  111. CAMINITI G, Fossati C, Rosano G, Volterrani M, et al
    Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77].
    Int J Cardiol. 2016 Sep 7. pii: S0167-5273(16)32050.
    PubMed     Text format    


    August 2016
  112. ARAMBULA-GARZA E, Castillo-Martinez L, Gonzalez-Islas D, Orea-Tejeda A, et al
    Association of cardiac cachexia and atrial fibrillation in heart failure patients.
    Int J Cardiol. 2016;223:863-866.
    PubMed     Text format     Abstract available


  113. KOSIUK J, Lindemann F, Hindricks G, Bollmann A, et al
    Need for further studies on ivabradine in patients with persistent atrial fibrillation.
    Int J Cardiol. 2016;223:915-916.
    PubMed     Text format    


  114. KOBAYASHI N, Yamawaki M, Nakano M, Hirano K, et al
    A new scoring system (DAIGA) for predicting bleeding complications in atrial fibrillation patients after drug-eluting stent implantation with triple antithrombotic therapy.
    Int J Cardiol. 2016;223:985-991.
    PubMed     Text format     Abstract available


  115. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study.
    Int J Cardiol. 2016;223:829-837.
    PubMed     Text format     Abstract available


  116. LEE SR, Choi EK, Rhee TM, Lee HJ, et al
    Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2016;223:953-957.
    PubMed     Text format     Abstract available


  117. DESTEGHE L, Engelhard L, Raymaekers Z, Kluts K, et al
    Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire.
    Int J Cardiol. 2016;223:906-914.
    PubMed     Text format     Abstract available


  118. WOLTERS FJ, Rizopoulos D, Ikram MA
    Dementia and death: Separate sides of the atrial fibrillation coin?
    Int J Cardiol. 2016 Aug 20. pii: S0167-5273(16)31962.
    PubMed     Text format    


  119. ALGHAMRY A, Hanna J, Pelecanos A, Kyranis S, et al
    Predictors of significant coronary artery disease in atrial fibrillation: Are cardiac troponins a useful measure.
    Int J Cardiol. 2016;223:744-749.
    PubMed     Text format     Abstract available


  120. PASTORI D, Pignatelli P, Perticone F, Sciacqua A, et al
    Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
    Int J Cardiol. 2016;223:619-624.
    PubMed     Text format     Abstract available


  121. OH S, Goto S, Accetta G, Angchaisuksiri P, et al
    Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry.
    Int J Cardiol. 2016;223:543-547.
    PubMed     Text format     Abstract available


  122. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Text format     Abstract available


  123. HASEGAWA K, Watanabe H, Hisamatsu T, Ohno S, et al
    Early repolarization and risk of arrhythmia events in long QT syndrome.
    Int J Cardiol. 2016;223:540-542.
    PubMed     Text format    


  124. CHEN D, Procter N, Goh V, Liu S, et al
    New onset atrial fibrillation is associated with elevated galectin-3 levels.
    Int J Cardiol. 2016;223:48-49.
    PubMed     Text format    


  125. BIERNACKA KE, Kukla P, Dubowski K, Wozniak O, et al
    Early repolarization in patients with arrhythmogenic right ventricular cardiomyopathy is not frequent phenomenon.
    Int J Cardiol. 2016;222:982-983.
    PubMed     Text format    


  126. NAGRA B, Awan MU, Miriyala V, Kantharia BK, et al
    Efficacy and limitations of treatment of ventricular fibrillation/ventricular tachycardia storm by subcutaneous implantable cardioverter defibrillator.
    Int J Cardiol. 2016;222:978-979.
    PubMed     Text format    


  127. SAFAK E, D'Ancona G, Ince H
    Inappropriate shocks after implantable cardioverter-defibrillator for primary prevention in idiopathic cardiomyopathy: Independent determinants.
    Int J Cardiol. 2016;223:512-513.
    PubMed     Text format    


  128. WONG CW, Chan YH, Cheng YH, Lam CS, et al
    Is overwork a precipitant factor of idiopathic ventricular fibrillation?
    Int J Cardiol. 2016;223:218-219.
    PubMed     Text format    


  129. SANI M, Ayubi E, Mansori K, Khazaei S, et al
    Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
    Int J Cardiol. 2016;222:949.
    PubMed     Text format    


  130. FEDELI U, Ferroni E, Pengo V
    Mortality associated to atrial fibrillation still on the rise: United States, 1999 to 2014.
    Int J Cardiol. 2016;222:788-789.
    PubMed     Text format    


  131. SHUAI W, Wang XX, Hong K, Peng Q, et al
    How to estimate heart rate from pulse rate reported by oscillometric method in atrial fibrillation: The value of pulse rate variation.
    Int J Cardiol. 2016;222:1022-1026.
    PubMed     Text format     Abstract available


  132. LU Y, Li K, Liu XS, Zhang N, et al
    Ivabradine and atrial fibrillation: A double-edged sword.
    Int J Cardiol. 2016;223:182-185.
    PubMed     Text format    


  133. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
    Oral anticoagulation in octogenarians with atrial fibrillation.
    Int J Cardiol. 2016;223:87-90.
    PubMed     Text format     Abstract available


  134. LEE HC, Chiu CC, Chen CC, Huang JW, et al
    Modulation of potassium channel KCNQ1 transcript in right atrial appendage of patients with postoperative atrial fibrillation.
    Int J Cardiol. 2016;222:696-698.
    PubMed     Text format    


  135. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
    Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
    PubMed     Text format     Abstract available


  136. SVENNBERG E, Lindahl B, Berglund L, Eggers KM, et al
    NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Int J Cardiol. 2016;223:74-81.
    PubMed     Text format     Abstract available


  137. ALEXANDER B, Rodriguez C, de la Isla LP, Islas F, et al
    The impact of advanced Interatrial block on new-onset atrial fibrillation following TAVR procedure.
    Int J Cardiol. 2016;223:672-673.
    PubMed     Text format    


  138. HOSSEINI S, Rezaei Y, Samiei N, Emkanjoo Z, et al
    Effects of mitral valve repair on ventricular arrhythmia in patients with mitral valve prolapse syndrome: A report of two cases.
    Int J Cardiol. 2016;222:603-605.
    PubMed     Text format    


  139. KIM Y, Lee SH
    Embolic stroke and after-admission atrial fibrillation.
    Int J Cardiol. 2016;222:576-580.
    PubMed     Text format     Abstract available


  140. YAO T, Tanaka K, Fujimura T, Murayama K, et al
    Plasma levels of oxidative stress-responsive apoptosis inducing protein (ORAIP) in patients with atrial fibrillation.
    Int J Cardiol. 2016;222:528-530.
    PubMed     Text format    


  141. BEDEIR K, Giugliano RP, Ramlawi B
    Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
    Int J Cardiol. 2016;222:615-619.
    PubMed     Text format     Abstract available


  142. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
    Obesity and atrial fibrillation.
    Int J Cardiol. 2016;223:159-160.
    PubMed     Text format    


  143. AGRAWAL S, Garg L, Nanda S, Sharma A, et al
    The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis.
    Int J Cardiol. 2016;222:379-384.
    PubMed     Text format     Abstract available


  144. CORTEZ-DIAS N, Costa MC, de Sousa J, Fiuza M, et al
    Expanding the functional role of miRNAs in the establishment of permanent atrial fibrillation.
    Int J Cardiol. 2016;222:340-341.
    PubMed     Text format    


  145. HAMON D, Algalarrondo V, Gandjbakhch E, Extramiana F, et al
    Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.
    Int J Cardiol. 2016;222:562-568.
    PubMed     Text format     Abstract available


    July 2016
  146. HAN R, Liu X, Yin X, Zheng M, et al
    Effect of remote ischemic preconditioning on myocardial injury and inflammatory response induced by ablation for atrial fibrillation: A randomized controlled trial.
    Int J Cardiol. 2016;222:396-400.
    PubMed     Text format     Abstract available


  147. BAHRAINY S, Levy WC, Busey JM, Caldwell JH, et al
    Exercise training bradycardia is largely explained by reduced intrinsic heart rate.
    Int J Cardiol. 2016;222:213-216.
    PubMed     Text format     Abstract available


  148. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
    Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
    Int J Cardiol. 2016;223:63-64.
    PubMed     Text format    


  149. ABDUL-KADIR NA, Mat Safri N, Othman MA
    Atrial fibrillation classification and association between the natural frequency and the autonomic nervous system.
    Int J Cardiol. 2016;222:504-508.
    PubMed     Text format     Abstract available


  150. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
    Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
    Int J Cardiol. 2016;222:430-435.
    PubMed     Text format     Abstract available


  151. ZHU W, Guo L, Hong K
    Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review.
    Int J Cardiol. 2016;222:289-294.
    PubMed     Text format     Abstract available


  152. TSAI FC, Lin YC, Chang SH, Chang GJ, et al
    Differential left-to-right atria gene expression ratio in human sinus rhythm and atrial fibrillation: Implications for arrhythmogenesis and thrombogenesis.
    Int J Cardiol. 2016;222:104-112.
    PubMed     Text format     Abstract available


  153. HE H, Guo J, Zhang A
    The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2016;221:827-830.
    PubMed     Text format     Abstract available


  154. BARBOSA MP, da Costa Rocha MO, Neto ES, Brandao FV, et al
    Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Int J Cardiol. 2016;222:80-85.
    PubMed     Text format     Abstract available


  155. WANDELL P, Carlsson AC, Holzmann MJ, Arnlov J, et al
    Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Int J Cardiol. 2016;221:789-793.
    PubMed     Text format     Abstract available


  156. MADIAS JE
    "Single beat only" recovery from stable left bundle branch block, engendered by an atrial premature beat.
    Int J Cardiol. 2016;221:770-771.
    PubMed     Text format    


  157. GARG L, Chen C, Haines DE
    Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
    Int J Cardiol. 2016;222:47-50.
    PubMed     Text format     Abstract available


  158. BRUNETTI ND, Santoro F, Correale M, De Gennaro L, et al
    Incidence of atrial fibrillation is associated with age and gender in subjects practicing physical exercise: A meta-analysis and meta-regression analysis.
    Int J Cardiol. 2016;221:1056-1060.
    PubMed     Text format     Abstract available


  159. CABRERA S, Valles E, Benito B, Alcalde O, et al
    Simple predictors for new onset atrial fibrillation.
    Int J Cardiol. 2016;221:515-520.
    PubMed     Text format     Abstract available


  160. SENOO K, Lip GY
    Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
    Int J Cardiol. 2016;221:379-382.
    PubMed     Text format     Abstract available


  161. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Text format     Abstract available


  162. KORNEJ J, Ueberham L, Schmidl J, Husser D, et al
    Addition of TGF-beta1 to existing clinical risk scores does not improve prediction for arrhythmia recurrences after catheter ablation of atrial fibrillation.
    Int J Cardiol. 2016;221:52-54.
    PubMed     Text format    


  163. WO HT, Liao FC, Chang PC, Chou CC, et al
    Circumferential ablation at the base of the left ventricular papillary muscles: A highly effective approach for ventricular arrhythmias originating from the papillary muscles.
    Int J Cardiol. 2016;220:876-882.
    PubMed     Text format     Abstract available


  164. SAIRAKU A, Yoshida Y, Nakano Y, Hirayama H, et al
    Don't expect left ventricular reverse remodeling after cardiac resynchronization therapy in patients with systolic heart failure and atrioventricular block: A multicenter study.
    Int J Cardiol. 2016;221:597-600.
    PubMed     Text format     Abstract available


    June 2016
  165. FUENMAYOR AJ, Rodriguez FJ, Gutierrez MD
    Successful catheter ablation in a patient with Scimitar and Wolff-Parkinson-White syndromes.
    Int J Cardiol. 2016;221:1048-1050.
    PubMed     Text format    


  166. HERMES IL, Marianna GS, Jessica RC, Carlos BR, et al
    Development and validation of a risk calculator predicting exercise-induced ventricular arrhythmia in patients with cardiovascular disease.
    Int J Cardiol. 2016;220:625-628.
    PubMed     Text format     Abstract available


  167. ZAMAN JA, Harling L, Ashrafian H, Darzi A, et al
    Post-operative atrial fibrillation is associated with a pre-existing structural and electrical substrate in human right atrial myocardium.
    Int J Cardiol. 2016;220:580-588.
    PubMed     Text format     Abstract available


  168. CAMELI M, Mandoli GE, Loiacono F, Sparla S, et al
    Left atrial strain: A useful index in atrial fibrillation.
    Int J Cardiol. 2016;220:208-213.
    PubMed     Text format     Abstract available


  169. MARZONA I, Baviera M, Vannini T, Tettamanti M, et al
    Risk of dementia and death in patients with atrial fibrillation: A competing risk analysis of a population-based cohort.
    Int J Cardiol. 2016;220:440-444.
    PubMed     Text format     Abstract available


  170. GOSTOLI S, Bonomo M, Roncuzzi R, Biffi M, et al
    Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD).
    Int J Cardiol. 2016;220:360-364.
    PubMed     Text format     Abstract available


  171. BEGG GA, Holden AV, Lip GY, Plein S, et al
    Assessment of atrial fibrosis for the rhythm control of atrial fibrillation.
    Int J Cardiol. 2016;220:155-161.
    PubMed     Text format     Abstract available


  172. CHOI EJ, Lee IH, Je NK
    Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
    Int J Cardiol. 2016;220:647-652.
    PubMed     Text format     Abstract available


  173. LANDSTROM AP, Boczek NJ, Ye D, Miyake CY, et al
    Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.
    Int J Cardiol. 2016;220:290-298.
    PubMed     Text format     Abstract available


  174. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available


  175. DE GENNARO L, Brunetti ND, Resta M, Rutigliano D, et al
    Cardiac arrest and ventricular fibrillation in a young man treated with capecitabine: Case report and literature review.
    Int J Cardiol. 2016;220:280-283.
    PubMed     Text format    


  176. ERTEKIN E, van Hagen IM, Salam AM, Ruys TP, et al
    Ventricular tachyarrhythmia during pregnancy in women with heart disease: Data from the ROPAC, a registry from the European Society of Cardiology.
    Int J Cardiol. 2016;220:131-136.
    PubMed     Text format     Abstract available


  177. BREMBILLA-PERROT B, Olivier A, Villemin T, Vincent J, et al
    Prediction of atrial fibrillation in patients with supraventricular tachyarrhythmias treated with catheter ablation or not. Classical scores are not useful.
    Int J Cardiol. 2016;220:102-106.
    PubMed     Text format     Abstract available


  178. WILSON DG, Leventigiannis G, Barr C, Morgan JM, et al
    ECG predictors of T wave oversensing in subcutaneous implantable cardioverter defibrillators.
    Int J Cardiol. 2016;220:27-31.
    PubMed     Text format     Abstract available


  179. SHALI S, Su Y, Ge J
    Interatrial septal pacing to suppress atrial fibrillation in patients with dual chamber pacemakers: A meta-analysis of randomized, controlled trials.
    Int J Cardiol. 2016;219:421-427.
    PubMed     Text format     Abstract available


  180. ZHAO YJ, Lin L, Zhou HJ, Tan KT, et al
    Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation.
    Int J Cardiol. 2016;220:794-801.
    PubMed     Text format     Abstract available


  181. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
    Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
    PubMed     Text format     Abstract available


  182. BELGAID DR, Khan Z, Zaidi M, Hobbs A, et al
    Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial.
    Int J Cardiol. 2016;219:177-179.
    PubMed     Text format     Abstract available


  183. AVILA P, Marcotte F, Dore A, Mercier LA, et al
    The impact of exercise on ventricular arrhythmias in adults with tetralogy of Fallot.
    Int J Cardiol. 2016;219:218-224.
    PubMed     Text format     Abstract available


  184. CHENG WL, Kao YH, Chen SA, Chen YJ, et al
    Pathophysiology of cancer therapy-provoked atrial fibrillation.
    Int J Cardiol. 2016;219:186-194.
    PubMed     Text format     Abstract available


  185. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
    Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Int J Cardiol. 2016;219:251-256.
    PubMed     Text format     Abstract available


    May 2016
  186. PETERS S
    The history of Brugada syndrome -- Continuum with arrhythmogenic cardiomyopathy or lone disease?
    Int J Cardiol. 2016;211:84-5.
    PubMed     Text format    


  187. VELOSO HH
    Why should we abort the expression 'aborted sudden death'.
    Int J Cardiol. 2016;211:67.
    PubMed     Text format    


  188. ZHU W, Yuan P, Shen Y, Wan R, et al
    Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies.
    Int J Cardiol. 2016;218:259-266.
    PubMed     Text format     Abstract available


  189. GARG J, Chaudhary R, Krishnamoorthy P, Palaniswamy C, et al
    Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials.
    Int J Cardiol. 2016;218:235-239.
    PubMed     Text format     Abstract available


  190. PENG L, Li S, Tang X, Luo Y, et al
    The prognostic value of exercise-induced ventricular arrhythmias in patients with and without coronary artery disease: A meta-analysis.
    Int J Cardiol. 2016;218:225-232.
    PubMed     Text format     Abstract available


  191. PHAN K, Khuong JN, Xu J, Kanagaratnam A, et al
    Obesity and postoperative atrial fibrillation in patients undergoing cardiac surgery: Systematic review and meta-analysis.
    Int J Cardiol. 2016;217:49-57.
    PubMed     Text format     Abstract available


  192. FAUCHIER L, Chaize G, Gaudin AF, Vainchtock A, et al
    Predictive ability of HAS-BLED, HEMORRHAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study.
    Int J Cardiol. 2016;217:85-91.
    PubMed     Text format     Abstract available


  193. GARCIA-FERNANDEZ A, Marin F, Roldan V, Galcera-Jornet E, et al
    The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
    Int J Cardiol. 2016;217:42-48.
    PubMed     Text format     Abstract available


  194. THAKAR S, Koshkelashvili N, Bucay MJ, Lichstein E, et al
    Electrocardiographic changes in patients >/= 100 years of age.
    Int J Cardiol. 2016;210:156-7.
    PubMed     Text format    


  195. KAO YH, Hsu JC, Chen YC, Lin YK, et al
    ZFHX3 knockdown increases arrhythmogenesis and dysregulates calcium homeostasis in HL-1 atrial myocytes.
    Int J Cardiol. 2016;210:85-92.
    PubMed     Text format     Abstract available


  196. DENDRAMIS G
    Brugada syndrome and Brugada phenocopy. The importance of a differential diagnosis.
    Int J Cardiol. 2016;210:25-7.
    PubMed     Text format     Abstract available


  197. BORNAUN H, Oztarhan K, Ocak Z, Ekiz A, et al
    Contribution of TGFB1 and TNF-alpha genes in one of twin pregnancies with congenital complete heart block phenotype.
    Int J Cardiol. 2016;210:16-8.
    PubMed     Text format    


    April 2016
  198. BOSSEAU C, Donal E
    Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients.
    Int J Cardiol. 2016 Apr 22. pii: S0167-5273(16)30278.
    PubMed     Text format    


  199. SHUAI W, Wang XX, Hong K, Peng Q, et al
    Is 10-second electrocardiogram recording enough for accurately estimating heart rate in atrial fibrillation.
    Int J Cardiol. 2016;215:175-178.
    PubMed     Text format     Abstract available


  200. PROIETTI M, Lane DA, Lip GY
    Relation of the SAMe-TTR score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trials.
    Int J Cardiol. 2016;216:168-172.
    PubMed     Text format     Abstract available


  201. SIMANTIRAKIS E, Marketou M, Kehagias E, Kanoupakis E, et al
    Symptomatic exercise-induced complete atrioventricular block due to severe superior vena cava stenosis.
    Int J Cardiol. 2016;215:167-168.
    PubMed     Text format    


  202. MODESTI PA, Colella A, Zhao D
    Atrial fibrillation in first generation Chinese migrants living in Europe: A proof of concept study.
    Int J Cardiol. 2016;215:269-272.
    PubMed     Text format     Abstract available


  203. HU XL, Chen Y, Zhou ZD, Ying J, et al
    Posterior pericardiotomy for the prevention of atrial fibrillation after coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;215:252-256.
    PubMed     Text format     Abstract available


  204. STOLLBERGER C, Finsterer J, Schneider B
    Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
    Int J Cardiol. 2016;216:186-187.
    PubMed     Text format    


  205. WIECZOREK J, Mizia-Stec K, Lasek-Bal A, Wieczorek P, et al
    CHA2DS2-Vasc score, age and body mass index as the main risk factors of hyperintense brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation.
    Int J Cardiol. 2016;215:476-481.
    PubMed     Text format     Abstract available


  206. NISHI T, Takaoka H, Funabashi N, Nishimura M, et al
    Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping.
    Int J Cardiol. 2016;209:248-52.
    PubMed     Text format    


  207. HAMMOND-HALEY M, Patel RS, Providencia R, Lambiase PD, et al
    Exercise restrictions for patients with inherited cardiac conditions: Current guidelines, challenges and limitations.
    Int J Cardiol. 2016;209:234-41.
    PubMed     Text format     Abstract available


  208. ZUCCHELLI G, Soldati E, Segreti L, Di Cori A, et al
    Incessant accelerated idioventricular rhythm in pregnancy: An unusual long lasting case.
    Int J Cardiol. 2016;209:151-2.
    PubMed     Text format    


  209. ALKHOULI M, Sarraf M, Zack CJ, Holmes DR, et al
    Iatrogenic atrial septal defect following transseptal cardiac interventions.
    Int J Cardiol. 2016;209:142-8.
    PubMed     Text format     Abstract available


  210. LIU R, Chang Q, Liu A
    Permanent atrial fibrillation: Special electrocardiogram in hyperkalemia.
    Int J Cardiol. 2016;215:519-520.
    PubMed     Text format    


  211. KANG SH, Choi EK, Han KD, Lee SR, et al
    Underweight is a risk factor for atrial fibrillation: A nationwide population-based study.
    Int J Cardiol. 2016;215:449-456.
    PubMed     Text format     Abstract available


  212. PETERS S
    Proof of an association between Morbus Ebstein and arrhythmogenic cardiomyopathy in a patient with chronic atrial fibrillation.
    Int J Cardiol. 2016;215:436-437.
    PubMed     Text format    


  213. SJALANDER S, Svensson PJ, Friberg L
    Atrial fibrillation patients with CHADS-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Int J Cardiol. 2016;215:360-363.
    PubMed     Text format     Abstract available


  214. JOHNSON SM, Brophy JM
    Mortality risk of sotalol and amiodarone for post-CABG atrial fibrillation.
    Int J Cardiol. 2016;214:502-507.
    PubMed     Text format     Abstract available


  215. JIE Q, Wang D, Liu B, Zhao D, et al
    Does left atrial appendage (LAA) occlusion device alter the echocardiography and electrocardiogram parameters in patients with atrial fibrillation?
    Int J Cardiol. 2016;215:494-501.
    PubMed     Text format     Abstract available


  216. MAEDA R, Minami Y, Haruki S, Kanbayashi K, et al
    Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Int J Cardiol. 2016;214:419-422.
    PubMed     Text format     Abstract available


  217. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
    Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
    Int J Cardiol. 2016;215:11-13.
    PubMed     Text format    


  218. ZIAEI F, Zaman M, Rasoul D, Gorantla RS, et al
    The prevalence of atrial fibrillation amongst heart failure patients increases with age.
    Int J Cardiol. 2016;214:410-411.
    PubMed     Text format    


  219. OZEKE O, Edipoglu E, Karakurt M, Karabulut O, et al
    Association of ST elevation with not only post-infarction ischemic apical aneurysm but also apical aneurysm associated with hypertrophic cardiomyopathy.
    Int J Cardiol. 2016;208:92-4.
    PubMed     Text format    


  220. EGBE AC, Connolly HM, Niaz T, McLeod CJ, et al
    Outcome of direct current cardioversion for atrial arrhythmia in adult Fontan patients.
    Int J Cardiol. 2016;208:115-9.
    PubMed     Text format     Abstract available


  221. MELOCHE J, Gottschalk BH, Boles U, LaHaye S, et al
    Hypophosphatemia as a novel etiology of Brugada Phenocopy.
    Int J Cardiol. 2016;208:70-1.
    PubMed     Text format    


  222. DE REGIBUS V, Rordorf R, Giorgianni C, Canclini C, et al
    Autosomal recessive atrial disease presenting with sick sinus syndrome (SSS), right atrial fibrosis and biatrial dilatation: Clinical impact of genetic diagnosis.
    Int J Cardiol. 2016;208:67-9.
    PubMed     Text format    


    March 2016
  223. XIANG R, Fan LL, Huang H, Zhao SP, et al
    Whole-exome sequencing identifies a novel mutation of DSG2 (Y198C) in a Chinese arrhythmogenic right ventricular cardiomyopathy patient.
    Int J Cardiol. 2016;214:1-3.
    PubMed     Text format    


  224. PETERS S
    Electrocardiographic morphology in right precordial T waves in arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2016;214:228.
    PubMed     Text format    


  225. SMEETS CJ, Lanssens D, Gyselaers W, Bertrand PB, et al
    Detection of subclinical transient fluid accumulation during pregnancy in a patient with an implantable cardioverter defibrillator and OptiVol(R) fluid monitoring algorithm.
    Int J Cardiol. 2016;214:163-165.
    PubMed     Text format    


  226. KOTECHA D
    Letter: Conflicting and unresolved issue of the prognostic value of atrial fibrillation for chronic heart failure patients - Response.
    Int J Cardiol. 2016 Mar 25. pii: S0167-5273(16)30529.
    PubMed     Text format    


  227. BOGOSSIAN H, Frommeyer G, Brachmann J, Lewalter T, et al
    Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: Who benefits and who does not? Data from the German ablation registry.
    Int J Cardiol. 2016;214:25-30.
    PubMed     Text format     Abstract available


  228. BASARAN O, Dogan V, Sahin C, Biteker M, et al
    Non-vitamin K antagonist oral anticoagulants in valvular atrial fibrillation.
    Int J Cardiol. 2016;212:357.
    PubMed     Text format    


  229. MADIAS JE
    Bradycardia and hypotension in a patient with subarachnoid hemorrhage-triggered takotsubo syndrome.
    Int J Cardiol. 2016;212:296.
    PubMed     Text format    


  230. NIERRAS PC, Maranian AP, Wen MS, Chou CC, et al
    Radiofrequency Catheter Ablation of Orthodromic Atrioventricular Reentrant Tachycardia in a Child with Congenitally Corrected Transposition of the Great Arteries and Atrial Septal Defect.
    Int J Cardiol. 2016;212:277-279.
    PubMed     Text format    


  231. WANG W, Yuan R, Korantzopoulos P, Xu G, et al
    Cystatin C and risk of atrial fibrillation in elderly hypertensive patients without chronic kidney disease.
    Int J Cardiol. 2016;212:262-264.
    PubMed     Text format    


  232. OZEKE O, Aras S, Baser K, Sen F, et al
    Defensive medicine due to different fears by patients and physicians in geriatric atrial fibrillation patients and second victim syndrome.
    Int J Cardiol. 2016;212:251-252.
    PubMed     Text format    


  233. EFTEKHARI A, Damgaard D, Grove EL
    Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
    Int J Cardiol. 2016;214:131-132.
    PubMed     Text format    


  234. BAEK YS, Kim TH, Uhm JS, Kim JY, et al
    Prevalence and the clinical outcome of atrial fibrillation in patients with Autoimmune Rheumatic Disease.
    Int J Cardiol. 2016;214:4-9.
    PubMed     Text format     Abstract available


  235. ZHANG N, Chen KY, Zhao J, Xu G, et al
    Another side effect of ticagrelor: Atrial fibrillation.
    Int J Cardiol. 2016;212:242-244.
    PubMed     Text format    


  236. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
    Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
    Int J Cardiol. 2016;212:311-317.
    PubMed     Text format     Abstract available


  237. COLEMAN CI, Tangirala M, Evers T
    Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
    Int J Cardiol. 2016;212:171-173.
    PubMed     Text format    


  238. ANZINI M, Merlo M, Artico J, Sinagra G, et al
    Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias.
    Int J Cardiol. 2016;212:169-170.
    PubMed     Text format    


  239. GIAMUNDO A, Canciello G, Rapacciuolo A, Musella F, et al
    Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy.
    Int J Cardiol. 2016;212:198-200.
    PubMed     Text format    


  240. QIU J, Zhou S, Liu Q
    Energy metabolic alterations in the progression of atrial fibrillation: Potential role of AMP-activated protein kinase as a critical regulator.
    Int J Cardiol. 2016;212:14-15.
    PubMed     Text format    


  241. OZEKE O, Cay S, Ozcan F, Topaloglu S, et al
    Lateral ST elevation as a practical electrocardiographic clue for apical aneurysm in hypertrophic cardiomyopathy patients.
    Int J Cardiol. 2016;207:194-5.
    PubMed     Text format    


  242. PARATO VM, Scarano M, Cicchitti V, Cannava G, et al
    An interventricular and right intraventricular dyssynchrony related to right bundle branch block appearance as cause of RVOT gradient decrease in a HCM patient.
    Int J Cardiol. 2016;207:150-1.
    PubMed     Text format    


  243. LIM E, Wong T
    Is non-sustained ventricular tachycardia a predictor of sudden death in adults with congenital heart disease?
    Int J Cardiol. 2016;207:264-5.
    PubMed     Text format    


  244. PETERS S
    The correlation between epsilon wave and coved-type ST-segment elevation in a patient with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2016;207:230.
    PubMed     Text format    


  245. PETERS S
    Ion channel diseases as a part in the definition and classification of cardiomyopathies recently confirmed in Brugada syndrome.
    Int J Cardiol. 2016;207:103.
    PubMed     Text format    


  246. PETERS S
    Diagnosis of arrhythmogenic cardiomyopathy by localized right precordial QRS prolongation and inferior early repolarization phenomenon but without T-wave inversion.
    Int J Cardiol. 2016;207:97-9.
    PubMed     Text format    


  247. DAUMY X, Amarouch MY, Lindenbaum P, Bonnaud S, et al
    Targeted resequencing identifies TRPM4 as a major gene predisposing to progressive familial heart block type I.
    Int J Cardiol. 2016;207:349-58.
    PubMed     Text format     Abstract available


  248. ARAS D, Topaloglu S, Ozeke O, Cay S, et al
    Left coronary cusp cryoablation guided by electroanatomic mapping for outflow ventricular arrhythmias.
    Int J Cardiol. 2016 Mar 3. pii: S0167-5273(16)30397.
    PubMed     Text format    


  249. OZEKE O, Cay S, Ozcan F, Baser K, et al
    Similarities between the renal artery and pulmonary vein denervation trials: Do we have to use sham procedures for atrial fibrillation catheter ablation trials?
    Int J Cardiol. 2016;211:55-57.
    PubMed     Text format    


  250. CHANG Q, Liu R
    True left bundle branch block?
    Int J Cardiol. 2016;211:112-114.
    PubMed     Text format    


  251. TEUWEN CP, Ramdjan TT, Gotte M, Brundel BJ, et al
    Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign?
    Int J Cardiol. 2016;206:158-63.
    PubMed     Text format     Abstract available


  252. D'AMATI G, De Caterina R, Basso C
    Sudden cardiac death in an Italian competitive athlete: Pre-participation screening and cardiovascular emergency care are both essential.
    Int J Cardiol. 2016;206:84-6.
    PubMed     Text format    


  253. CHOU CA, Zhou L, Blanchard MS
    Invasive vagal nerve stimulation causes delayed autonomic dysregulation: A case report.
    Int J Cardiol. 2016;206:19-20.
    PubMed     Text format    


    February 2016
  254. AKDIS D, Saguner AM, Brunckhorst CB, Duru F, et al
    Successful epicardial ablation of ventricular tachycardia in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2016;211:22-24.
    PubMed     Text format    


  255. QIN M, Liu X, Jiang WF, Wu SH, et al
    Vagal response during pulmonary vein isolation: Re-recognized its characteristics and implications in lone paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;211:7-13.
    PubMed     Text format     Abstract available


  256. YAMABE H, Kanazawa H, Itoh M, Kaneko S, et al
    Difference in the maintenance mechanism of atrial fibrillation perpetuated after pulmonary vein isolation between paroxysmal and persistent atrial fibrillation: Effects of subsequent stepwise ablation.
    Int J Cardiol. 2016;210:109-118.
    PubMed     Text format     Abstract available


  257. MENG L, Yang Y, Zhang Z, Li G, et al
    Predictive value of circulating fibroblast growth factor-23 on atrial fibrillation: A meta-analysis.
    Int J Cardiol. 2016;210:68-71.
    PubMed     Text format    


  258. GANGA HV, Jantz J, Puppala VK
    Risk of incident atrial fibrillation with hypomagnesemia.
    Int J Cardiol. 2016 Feb 15. pii: S0167-5273(16)30241.
    PubMed     Text format    


  259. VILLATORO MA, Marquez MF, Gomez-Flores J, Nava S, et al
    Andersen-Tawil syndrome. A diagnostic challenge.
    Int J Cardiol. 2016;205:163-4.
    PubMed     Text format    


  260. GAL P, Elvan A, Rossi P, Schauerte P, et al
    Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics.
    Int J Cardiol. 2016;205:83-5.
    PubMed     Text format    


  261. ZHOU GB, Hu JQ, Guo XG, Liu X, et al
    Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar.
    Int J Cardiol. 2016;205:72-80.
    PubMed     Text format     Abstract available


  262. FURUTA A, Lellouche N, Mouillet G, Dhanjal T, et al
    Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.
    Int J Cardiol. 2016;210:72-79.
    PubMed     Text format     Abstract available


  263. HU X, Jiang J, Ma Y, Tang A, et al
    Is there still a role for additional linear ablation in addition to pulmonary vein isolation in patients with paroxysmal atrial fibrillation? An Updated Meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;209:266-274.
    PubMed     Text format     Abstract available


  264. SCHERLAG BJ, Sun J, He B, Po SS, et al
    Optimal Sites for Renal Artery Denervation: Relation to atrial fibrillation ablation.
    Int J Cardiol. 2016;209:330-331.
    PubMed     Text format    


  265. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  266. PETERS S
    Differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and granulomatous myocarditis by advanced ECG analysis.
    Int J Cardiol. 2016;209:255-257.
    PubMed     Text format    


  267. SEO WK, Kang SH, Jung JM, Choi JY, et al
    Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
    Int J Cardiol. 2016;209:184-189.
    PubMed     Text format     Abstract available


  268. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease.
    Int J Cardiol. 2016;209:181-183.
    PubMed     Text format    


  269. TOPALOGLU S, Ozeke O, Ozcan F, Aras D, et al
    Anatomical considerations in accessory pathway ablation.
    Int J Cardiol. 2016;204:122-3.
    PubMed     Text format    


  270. KETTERER U, D'Ancona G, Siegel I, Ortak J, et al
    Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders.
    Int J Cardiol. 2016;204:196-7.
    PubMed     Text format    


  271. BUSUTTIL M, Willoughby S
    A survey of energy drink consumption among young patients presenting to the emergency department with the symptom of palpitations.
    Int J Cardiol. 2016;204:55-6.
    PubMed     Text format    


    January 2016
  272. BRIFFA T, Hung J, Knuiman M, McQuillan B, et al
    Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995-2010.
    Int J Cardiol. 2016;208:19-25.
    PubMed     Text format     Abstract available


  273. QIU J, Zhou S, Liu Q
    Phosphorylated AMP-activated protein kinase slows down the atrial fibrillation progression by activating Connexin43.
    Int J Cardiol. 2016;208:56-57.
    PubMed     Text format    


  274. RUF T, Mues C, Tomala J, Ibrahim K, et al
    TAVR - A new way to treat ventricular storm and ventricular fibrillation.
    Int J Cardiol. 2016;208:36-39.
    PubMed     Text format    


  275. BALTA S, Demirkol S, Aparci M, Yildirim AO, et al
    Red blood cell distribution width: Just one of many things to consider.
    Int J Cardiol. 2016;203:438-9.
    PubMed     Text format    


  276. RAMOUTAR A, Bowker T, Kurbaan A, Xiao HB, et al
    Response to "Pacemaker indication in first-degree AV block patients: Factors beyond the PR interval/HR slope".
    Int J Cardiol. 2016;203:1152.
    PubMed     Text format    


  277. AKRAWINTHAWONG K, Mehdirad AA
    Pacemaker indication in first-degree AV block patients: Factors beyond the PR interval/HR slope.
    Int J Cardiol. 2016;203:1151.
    PubMed     Text format    


  278. CHAUDHRY UA, Harling L, Ashrafian H, Athanasiou C, et al
    Surgical management of infected cardiac implantable electronic devices.
    Int J Cardiol. 2016;203:714-21.
    PubMed     Text format     Abstract available


  279. PETERS S
    Brugada phenocopy in percutaneous coronary intervention of the right coronary artery.
    Int J Cardiol. 2016;203:675.
    PubMed     Text format    


  280. GIGANTE A, Rosato E, Liberatori M, Sardo L, et al
    In systemic sclerosis prolonged QTc interval is associated with reduced exercise tolerance.
    Int J Cardiol. 2016;203:570-2.
    PubMed     Text format    


  281. KALENDER E, Sensoy B, Cay S
    Heart block after herpes zoster reactivation.
    Int J Cardiol. 2016;203:549-50.
    PubMed     Text format    


  282. BATTAGLIA A, Anselmino M, Ferraris F, Gaita F, et al
    Left persistent superior vena cava as a source of focal atrial arrhythmias: A late arrhythmia recurrence due to a latent proximal focus.
    Int J Cardiol. 2016;203:523-4.
    PubMed     Text format    


  283. WILSON DG, Yue A, Roberts PR, Morgan JM, et al
    Leadless pacing: The old with the new.
    Int J Cardiol. 2016;203:407-8.
    PubMed     Text format    


  284. LEE YJ, Park JK, Uhm JS, Kim JY, et al
    Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Int J Cardiol. 2016;203:372-8.
    PubMed     Text format     Abstract available


  285. ONER T, Akdeniz C, Adaletli H
    Multifocal atrial tachycardia caused by risperidone.
    Int J Cardiol. 2016;203:855-7.
    PubMed     Text format     Abstract available


  286. LU Z, He B, He W, Xie J, et al
    Electrocardiographic characteristics of idiopathic premature ventricular contractions originating from the junction of the right ventricular outflow tract and tricuspid annulus.
    Int J Cardiol. 2016;203:5-11.
    PubMed     Text format     Abstract available


  287. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.
    PubMed     Text format    


  288. BREMBILLA-PERROT B, Sellal JM, Olivier A, Villemin T, et al
    Electrophysiological study generally is negative in patients <40 years suspected of supraventricular tachycardia but also complaining of chest pain and/or syncope.
    Int J Cardiol. 2016;203:1109-13.
    PubMed     Text format     Abstract available


  289. SWEETING J, Ingles J, Ball K, Semsarian C, et al
    Sudden deaths during the largest community running event in Australia: A 25-year review.
    Int J Cardiol. 2016;203:1029-31.
    PubMed     Text format    


  290. ITO S, Stout KK, Robinson MR
    Non-sustained ventricular tachycardia in a pregnant woman with repaired Tetralogy of Fallot: A challenging case.
    Int J Cardiol. 2016;203:1133-4.
    PubMed     Text format    


  291. ROMANO P, Messina F, Crosca S
    Oral anticoagulant therapy and thrombosis. A case of failure of therapy with vitamin K antagonists.
    Int J Cardiol. 2016;203:1158-9.
    PubMed     Text format    


  292. SHAH N, Rochlani Y, Pothineni NV, Paydak H, et al
    Burden of arrhythmias in patients with multiple myeloma.
    Int J Cardiol. 2016;203:305-6.
    PubMed     Text format    


  293. JOLOBE OM
    Long term supervision as a crucial ingredient of all anticoagulant therapy.
    Int J Cardiol. 2016;203:278.
    PubMed     Text format    


  294. MADIAS JE
    Takotsubo syndrome/QTc interval prolongation/myocardial edema/cardiac sympathetic denervation/cardiac arrhythmias: A quintet needing exploration.
    Int J Cardiol. 2016;203:259-61.
    PubMed     Text format    


  295. BITEKER M, Basaran O, Dogan V
    Prediction of atrial fibrillation risk in the community.
    Int J Cardiol. 2016 Jan 14. pii: S0167-5273(16)30126.
    PubMed     Text format    


  296. PROIETTI M, Raparelli V, Basili S, Olshansky B, et al
    Relation of female sex to left atrial diameter and cardiovascular death in atrial fibrillation: The AFFIRM Trial.
    Int J Cardiol. 2016;207:258-263.
    PubMed     Text format     Abstract available


  297. PETERS S
    Tachycardiomyopathy: A case of dilated cardiomyopathy due to permanent junctional reentrant tachycardia.
    Int J Cardiol. 2016;207:233-234.
    PubMed     Text format    


  298. ZHANG X, Zhang Z, Li M, Li G, et al
    Potential role of dipeptidyl peptidase-4 inhibitors in atrial fibrillation.
    Int J Cardiol. 2016;207:46-47.
    PubMed     Text format    


  299. KEFER J, Tzikas A, Freixa X, Shakir S, et al
    Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Int J Cardiol. 2016;207:335-340.
    PubMed     Text format     Abstract available


  300. SANTOS-LOZANO A, Sanchis-Gomar F, Barrero-Santalla S, Pareja-Galeano H, et al
    Exercise as an adjuvant therapy against chronic atrial fibrillation.
    Int J Cardiol. 2016;207:180-184.
    PubMed     Text format    


  301. PETERS S
    A case of atrioventricular nodal reentrant tachycardia associated with arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2016;207:143-144.
    PubMed     Text format    


  302. APARCI M, Uz O, Atalay M, Uzun M, et al
    May hypomagnesaemia; caused by proton pump inhibitor; increase atrial fibrillation risk?
    Int J Cardiol. 2016;207:141.
    PubMed     Text format    


  303. KIRAT T, Kose N, Altun I, Akin F, et al
    What is the role of routine ECG screening in stable coronary heart disease and effects of oral anticoagulant, antiarrhythmics in these patients with atrial fibrillation?
    Int J Cardiol. 2016;207:140.
    PubMed     Text format    


  304. KAYA H, Beton O, Yilmaz MB
    Atrial fibrillation and D dimer levels for patients with acute decompensated heart failure.
    Int J Cardiol. 2016;207:136.
    PubMed     Text format    


  305. DARWICHE W, Bejan-Angoulvant T, Dievart F, Babuty D, et al
    Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings.
    Int J Cardiol. 2016;206:89-92.
    PubMed     Text format    


  306. SAWHNEY V, Campbell NG, Brouilette SW, Coppen SR, et al
    Telomere shortening and telomerase activity in ischaemic cardiomyopathy patients - Potential markers of ventricular arrhythmia.
    Int J Cardiol. 2016;207:157-163.
    PubMed     Text format     Abstract available


  307. MERINOPOULOS I, Raphael CE, Yardley A, Goonewardene M, et al
    Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?
    Int J Cardiol. 2016;207:378-381.
    PubMed     Text format     Abstract available


  308. SHAO Q, Korantzopoulos P, Fu H, Ye L, et al
    Effects of probucol on left atrial remodeling in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2016;207:117-119.
    PubMed     Text format    


  309. ONDRAKOVA M, Knot J, Ulman J, Maly M, et al
    Efficacy of P2Y receptor antagonists in patients with atrial fibrillation according to the CHADSVASc score.
    Int J Cardiol. 2016;207:84-86.
    PubMed     Text format    


  310. SECCIA TM, Caroccia B, Muiesan ML, Rossi GP, et al
    Atrial fibrillation and arterial hypertension: A common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role.
    Int J Cardiol. 2016;206:71-76.
    PubMed     Text format     Abstract available


  311. BAVISHI C, Khan AR, Ather S
    Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
    Int J Cardiol. 2016;206:56-57.
    PubMed     Text format    


  312. GOLDBERG A, Rosenfeld I, Nordkin I, Halabi M, et al
    Ticagrelor therapy in patients with advanced conduction disease: Is it really safe?
    Int J Cardiol. 2016;202:948-9.
    PubMed     Text format    


  313. CHRISTOS GA
    P-wave indices in emphysema. What do we actually know?
    Int J Cardiol. 2016;202:80.
    PubMed     Text format    


  314. ZARROUK-MAHJOUB S, Finsterer J
    Noncompaction with valve abnormalities is rarely associated with neurologic or genetic disease.
    Int J Cardiol. 2016;202:627-8.
    PubMed     Text format    


  315. DATINO T, Arenal A, Ruiz-Hernandez PM, Pelliza M, et al
    Arrhythmia ablation using the Amigo Robotic Remote Catheter System versus manual ablation: One year follow-up results.
    Int J Cardiol. 2016;202:877-8.
    PubMed     Text format    


  316. HUANG SY, Chen YC, Kao YH, Hsieh MH, et al
    Renal failure induces atrial arrhythmogenesis from discrepant electrophysiological remodeling and calcium regulation in pulmonary veins, sinoatrial node, and atria.
    Int J Cardiol. 2016;202:846-57.
    PubMed     Text format     Abstract available


  317. HUNG MJ, Mao CT, Yang NI, Kao YC, et al
    Delayed recovery of anger-induced electrocardiographic T-wave alternans and T-wave inversion in a previously healthy woman.
    Int J Cardiol. 2016;202:707-9.
    PubMed     Text format    


  318. GIALAFOS E, Andreadou E, Kokotis P, Evangelopoulos ME, et al
    Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
    Int J Cardiol. 2016;202:652-3.
    PubMed     Text format    


  319. VAN DER BOON RM, van Huysduynen BH, Meuwissen M, Schaap J, et al
    Ventricular tachycardia: The challenge of two diagnoses.
    Int J Cardiol. 2016;202:226-7.
    PubMed     Text format    


  320. SOLIMENE F, Donnici G, Shopova G, Nappi F, et al
    Trends in fluoroscopy time during radiofrequency catheter ablation of supraventricular tachycardias.
    Int J Cardiol. 2016;202:124-5.
    PubMed     Text format    


  321. PARATO VM, Scarano M, Cicchitti V, Cannava G, et al
    Involvement of the right ventricle in hypertrophic cardiomyopathy and occurrence of right bundle branch block.
    Int J Cardiol. 2016;202:75-6.
    PubMed     Text format    


  322. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
    Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Int J Cardiol. 2016;202:578-85.
    PubMed     Text format     Abstract available


  323. NISHIMURA K, Funabashi N, Takahashi Y, Hasegawa H, et al
    Cardiac Fabry disease with plural mass fibrosis observed in the thickened left ventricular wall.
    Int J Cardiol. 2016;202:552-5.
    PubMed     Text format    


  324. XIA W, Liu Y
    Targeted ablation of cardiac sympathetic neurons: A promising approach to prevent sudden cardiac death.
    Int J Cardiol. 2016;202:425-6.
    PubMed     Text format    


  325. SOMMESE L, Valverde CA, Blanco P, Castro MC, et al
    Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.
    Int J Cardiol. 2016;202:394-406.
    PubMed     Text format     Abstract available


    December 2015
  326. MARKOVITS N, Kurnik D, Halkin H, Margalit R, et al
    Database evaluation of the association between serum magnesium levels and the risk of atrial fibrillation in the community.
    Int J Cardiol. 2015;205:142-146.
    PubMed     Text format     Abstract available


  327. DIOUF I, Magliano DJ, Carrington MJ, Stewart S, et al
    Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: The Australian Diabetes, Obesity and Lifestyle (AusDiab) longitudinal, population cohort study.
    Int J Cardiol. 2015;205:127-132.
    PubMed     Text format     Abstract available


  328. LEE A, See VA, Lim TW, Descallar J, et al
    Atrial fibrillation ablation by single ring isolation versus wide antral isolation: Effects on left atrial size and function.
    Int J Cardiol. 2015;206:1-6.
    PubMed     Text format     Abstract available


  329. CHHABRA L, Gurukripa Kowlgi N
    Cardiac adipose tissue: Distinction between epicardial and pericardial fat remains important!
    Int J Cardiol. 2015;201:274-5.
    PubMed     Text format    


    November 2015
  330. KOIFMAN E, Lipinski MJ, Escarcega RO, Didier R, et al
    Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis.
    Int J Cardiol. 2015;205:17-22.
    PubMed     Text format     Abstract available


  331. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
    Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
    Int J Cardiol. 2015;203:906-908.
    PubMed     Text format    


  332. PETERS S
    Refugee from Syria presents with chest pain due to arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;204:59-60.
    PubMed     Text format    


  333. SZYMANSKI FM, Lip GY, Filipiak KJ, Platek AE, et al
    Usefulness of the SAME-TTR score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.
    Int J Cardiol. 2015;204:200-205.
    PubMed     Text format     Abstract available


  334. CEKIRDEKCI E, Emre E
    e-Comment: There is no magic bullet to predict postoperative atrial fibrillation.
    Int J Cardiol. 2015;204:114.
    PubMed     Text format    


  335. ZHAO J, Liu T, Korantzopoulos P, Letsas KP, et al
    Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis.
    Int J Cardiol. 2015;204:103-105.
    PubMed     Text format    


  336. VELOSO HH, Chaves JC, Jazbik Sobrinho J
    Inappropriate shocks of implantable cardioverter-defibrillator during central venous access: A preventable complication.
    Int J Cardiol. 2015;204:61-63.
    PubMed     Text format    


  337. VELOSO HH
    Underutilization of implantable cardioverter-defibrillator in studies proposing risk scores to predict death in Chagas heart disease: Just a reflection of the real world.
    Int J Cardiol. 2015;203:1082-1083.
    PubMed     Text format    


  338. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
    Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
    Int J Cardiol. 2015;203:1014-1015.
    PubMed     Text format    


  339. HE B, Lu Z, He W, Huang B, et al
    Ventricular arrhythmias as an autoimmune disorder?
    Int J Cardiol. 2015;203:1011-1012.
    PubMed     Text format    


  340. KUNDU A, Sen P, Sardar P, Chatterjee S, et al
    Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2015;203:1000-1002.
    PubMed     Text format    


  341. ANCEDY Y, Lecoq C, Saint Etienne C, Ivanes F, et al
    Antithrombotic management in patients with atrial fibrillation undergoing coronary stent implantation: What is the impact of guideline adherence?
    Int J Cardiol. 2015;203:987-994.
    PubMed     Text format     Abstract available


  342. TOKATLI A, Yiginer O
    Altered atrial conduction in postoperative atrial fibrillation.
    Int J Cardiol. 2015;203:945-946.
    PubMed     Text format    


  343. LIP GY, Mitchell SA, Liu X, Liu LZ, et al
    Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Int J Cardiol. 2015;204:88-94.
    PubMed     Text format     Abstract available


  344. PETERS S
    Unusual cause of chest pain in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;204:13-14.
    PubMed     Text format    


  345. KATO S, Foppa M, Roujol S, Basha T, et al
    Left ventricular native T time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Int J Cardiol. 2015;203:848-854.
    PubMed     Text format     Abstract available


  346. NEDIOS S, Seewoster T, Lip GH, Husser D, et al
    Association between peripheral plasma markers and left atrial anatomy in patients with atrial fibrillation.
    Int J Cardiol. 2015;203:621-623.
    PubMed     Text format    


  347. LI H, Liu T, Xu G, Liu E, et al
    Red blood cell distribution width and the recurrence of atrial fibrillation after ablation in patients with paroxysmal non-valvular symptomatic atrial fibrillation.
    Int J Cardiol. 2015;203:834-836.
    PubMed     Text format    


  348. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
    A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
    Int J Cardiol. 2015;203:785-790.
    PubMed     Text format     Abstract available


  349. MATSUBARA TJ, Fujiu K, Asada K, Kojima T, et al
    Direct left atrial ICE imaging guided ablation for atrial fibrillation without employing contrast medium.
    Int J Cardiol. 2015;203:733-739.
    PubMed     Text format     Abstract available


  350. YANG Y, Liu Q, Wu Z, Li X, et al
    Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;203:624-625.
    PubMed     Text format    


  351. OZTURK C, Unlu M, Yildirim AO, Erdogan S, et al
    The progressed atrioventricular block associated with ticagrelor therapy may not require permanent pacemaker after acute coronary syndrome; it may be reversible.
    Int J Cardiol. 2015;203:822-824.
    PubMed     Text format    


  352. QIU J, Hu H, Zhou S, Liu Q, et al
    Alteration of myocardium glucose metabolism in atrial fibrillation: Cause or effect?
    Int J Cardiol. 2015;203:722-723.
    PubMed     Text format    


    October 2015
  353. KATO Y, Suzuki S, Kano H, Semba H, et al
    Prognostic significance of exercise capacity and resting heart rate: Comparison between atrial fibrillation and sinus rhythm.
    Int J Cardiol. 2015;203:561-563.
    PubMed     Text format    


  354. EYUBOGLU M
    Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
    Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
    PubMed     Text format    


  355. MADAN A, Yan W, Byrne P, Ward M, et al
    Significance of left atrial appendage filling defects on cardiac CT prior to pulmonary vein isolation for atrial fibrillation.
    Int J Cardiol. 2015;203:520-522.
    PubMed     Text format    


  356. KOTECHA D, Chudasama R, Lane DA, Kirchhof P, et al
    Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Int J Cardiol. 2015;203:660-666.
    PubMed     Text format     Abstract available


  357. LIU Y, Zhang Z, Yang Y, Zhang N, et al
    The Chinese herb extract Wenxin Keli: A promising agent for the management of atrial fibrillation.
    Int J Cardiol. 2015;203:614-615.
    PubMed     Text format    


  358. VERBERK WJ, Omboni S, Kollias A, Stergiou GS, et al
    Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations.
    Int J Cardiol. 2015;203:465-473.
    PubMed     Text format     Abstract available


  359. LIU T, Meng XY, Li T, Fu ZL, et al
    Atherosclerosis is critical in the pathogenesis of erectile dysfunction.
    Int J Cardiol. 2015;203:367-368.
    PubMed     Text format    


  360. FARYAN M, Kamycka E, Stec KM, Wojakowski W, et al
    Mobilization of stem and progenitor cells in patients with atrial fibrillation undergoing circumferential pulmonary vein isolation.
    Int J Cardiol. 2015;203:415-417.
    PubMed     Text format    


  361. BARRA S, Providencia R, Agarwal S
    Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?
    Int J Cardiol. 2015;203:184-186.
    PubMed     Text format    


  362. LARSSON SC, Drca N, Jensen-Urstad M, Wolk A, et al
    Combined impact of healthy lifestyle factors on risk of atrial fibrillation: Prospective study in men and women.
    Int J Cardiol. 2015;203:46-49.
    PubMed     Text format     Abstract available


  363. OLGUN KUCUK H, Kucuk U, Yalcin M, Isilak Z, et al
    Time to use mobile health devices to diagnose paroxysmal atrial fibrillation.
    Int J Cardiol. 2015 Oct 21. pii: S0167-5273(15)30722.
    PubMed     Text format    


  364. PETERS S
    Confusion with the diagnosis of acute pulmonary embolism and arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;203:317.
    PubMed     Text format    


  365. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
    Strokes after cardioversion of atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2015;203:269-273.
    PubMed     Text format    


  366. CHEN Y, Huang W, Huang Y, Hu Y, et al
    Beta-blockers treatment in heart failure with atrial fibrillation - Who should we believe?
    Int J Cardiol. 2015;203:60-61.
    PubMed     Text format    


  367. LAZZERONI D, Parati G, Bini M, Piazza P, et al
    P-wave dispersion predicts atrial fibrillation following cardiac surgery.
    Int J Cardiol. 2015;203:131-133.
    PubMed     Text format    


  368. ELMAS E, Tulumen E, Liebe V, Rudic B, et al
    Mid-regional pro-adrenomedullin and N-terminal pro B-type natriuretic peptide predict the recurrence of atrial fibrillation after cryoballoon pulmonary vein isolation.
    Int J Cardiol. 2015;203:369-371.
    PubMed     Text format    


  369. DESHMUKH A, Pothineni NV, Patel N, Badheka A, et al
    Trends in hospitalizations of young patients with atrial fibrillation: A cause for concern?
    Int J Cardiol. 2015;203:164-165.
    PubMed     Text format    


  370. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
    New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
    Int J Cardiol. 2015;203:264-266.
    PubMed     Text format    


  371. FERRARI R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, et al
    An update on atrial fibrillation in 2014: From pathophysiology to treatment.
    Int J Cardiol. 2015;203:22-29.
    PubMed     Text format     Abstract available


  372. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  373. ZHOU Q, Zhou X, TuEr-Hong ZL, Wang H, et al
    Renal sympathetic denervation suppresses atrial fibrillation induced by acute atrial ischemia/infarction through inhibition of cardiac sympathetic activity.
    Int J Cardiol. 2015;203:187-195.
    PubMed     Text format     Abstract available


  374. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
    Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
    PubMed     Text format    


  375. ZHOU X, Zhang W, Lv W, Zhou Q, et al
    Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Int J Cardiol. 2015;203:55-59.
    PubMed     Text format     Abstract available


  376. PANKERT M, Salaun E, Cuisset T, Bonnet JL, et al
    A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.
    Int J Cardiol. 2015;202:900-903.
    PubMed     Text format    


  377. SHIN DG, Mun HS, Lee HY, Hwang ES, et al
    The effect of transesophageal echocardiography on the incidence of thromboembolism after electrical cardioversion in atrial fibrillation: A multicenter analysis.
    Int J Cardiol. 2015;202:880-882.
    PubMed     Text format    


  378. KOUNIS NG, Cervellin G, Lippi G
    Cisplatin-induced bradycardia: Cardiac toxicity or cardiac hypersensitivity and Kounis syndrome?
    Int J Cardiol. 2015;202:817-818.
    PubMed     Text format    


  379. DAI J, Zhang H, Chen Y, Chang Y, et al
    Characterization of Ca handling proteins and contractile proteins in patients with lone atrial fibrillation.
    Int J Cardiol. 2015;202:749-751.
    PubMed     Text format    


  380. SAED D, Arasteh P
    Paradoxical thromboembolism despite prophylactic antithrombotic therapy in atrial fibrillation: A case report.
    Int J Cardiol. 2015;203:338-340.
    PubMed     Text format    


  381. AMASYALI B, Tek M
    The type of spontaneous termination of supraventricular tachycardia: What does it tell us?
    Int J Cardiol. 2015;196:29-30.
    PubMed     Text format    


    September 2015
  382. HE B, Huang B, Lu Z, He W, et al
    Galectin-3: A potential new target for upstream therapy of atrial fibrillation.
    Int J Cardiol. 2015 Sep 29. pii: S0167-5273(15)30500.
    PubMed     Text format    


  383. HUANG Y, Huang W, Hu Y
    Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality?
    Int J Cardiol. 2015 Sep 27. pii: S0167-5273(15)30521.
    PubMed     Text format    


  384. BERTI D, Van Vlasselaer X, Moons P, Heidbuchel H, et al
    Prioritized outcomes to evaluate the effectiveness of atrial fibrillation disease management: A systematic review and Delphi study.
    Int J Cardiol. 2015;202:500-503.
    PubMed     Text format    


  385. BORDACHAR P, Marquie C, Pospiech T, Pasquie JL, et al
    Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease.
    Int J Cardiol. 2015;203:251-258.
    PubMed     Text format     Abstract available


  386. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
    Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2015;202:589-594.
    PubMed     Text format     Abstract available


  387. WEEDA ER, Hodgdon N, Do T, Unachukwu K, et al
    Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs.
    Int J Cardiol. 2015;202:427-429.
    PubMed     Text format    


  388. PETERS S
    Left precordial JT prolongation in arrhythmogenic right ventricular cardiomyopathy: Risk assessment revisited.
    Int J Cardiol. 2015;202:745-746.
    PubMed     Text format    


  389. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
    REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
    Int J Cardiol. 2015;203:882-884.
    PubMed     Text format    


  390. WANDELL P, Carlsson AC, Gasevic D, Sundquist J, et al
    Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.
    Int J Cardiol. 2015;202:776-781.
    PubMed     Text format     Abstract available


  391. LINDE C, Curtis AB, Fonarow GC, Lee K, et al
    Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study.
    Int J Cardiol. 2015;202:349-355.
    PubMed     Text format     Abstract available


  392. FERNANDEZ-CISNAL A, Arce-Leon A, Arana-Rueda E, Rodriguez-Manero M, et al
    Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses.
    Int J Cardiol. 2015;195:188-94.
    PubMed     Text format     Abstract available


  393. PIJUAN-DOMENECH A, Galian L, Goya M, Casellas M, et al
    Cardiac complications during pregnancy are better predicted with the modified WHO risk score.
    Int J Cardiol. 2015;195:149-54.
    PubMed     Text format     Abstract available


  394. OLDE NORDKAMP LR, Brouwer TF, Barr C, Theuns DA, et al
    Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Int J Cardiol. 2015;195:126-33.
    PubMed     Text format     Abstract available


  395. EL MAZLOUM R, Snenghi R, Zorzi A, Zilio F, et al
    Out-of-hospital cardiac arrest after acute cocaine intoxication associated with Brugada ECG patterns: Insights into physiopathologic mechanisms and implications for therapy.
    Int J Cardiol. 2015;195:245-9.
    PubMed     Text format    


  396. MADIAS JE
    Delving into the issue of life-threatening arrhythmias in patients with Takotsubo syndrome.
    Int J Cardiol. 2015;195:215.
    PubMed     Text format    


  397. ARONIS KN, Thigpen JL, Tripodis Y, Dillon C, et al
    Paroxysmal atrial fibrillation and the hazards of under-treatment.
    Int J Cardiol. 2015;202:214-220.
    PubMed     Text format     Abstract available


  398. RODRIGUEZ-MANERO M, Gonzalez-Melchor L, Ballesteros G, Raposeiras-Roubin S, et al
    Risk of pacemaker implantation after uneventful successful cavotricuspid isthmus radiofrequency ablation in patients with common atrial flutter.
    Int J Cardiol. 2015;202:285-288.
    PubMed     Text format     Abstract available


  399. LIU F, Li Y, Xu Y
    Weight loss to prevent atrial fibrillation: The role of epicardial adipose tissue.
    Int J Cardiol. 2015;204:124-125.
    PubMed     Text format    


    August 2015
  400. GIUSEPPE C, Chiara F, Giuseppe R, Maurizio V, et al
    Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.
    Int J Cardiol. 2015;202:73-74.
    PubMed     Text format    


  401. DE GENNARO L, Modugno G, Sportelli G, Pellegrino PL, et al
    Clinical follow-up of atrial-fibrillation patients treated with novel oral anti-coagulants: A multi-disciplinary consensus from the Apulia section of the Italian Association of Hospital Cardiologists (ANMCO).
    Int J Cardiol. 2015;202:265-272.
    PubMed     Text format     Abstract available


  402. WASMER K, Reinecke H
    Response to the letter regarding article "Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease".
    Int J Cardiol. 2015;203:519.
    PubMed     Text format    


  403. MESSINA F, Romano P, Paino M, Crosca S, et al
    Long-term complication of the thoracic radiation in breast cancer: An complete atrioventricular block case.
    Int J Cardiol. 2015;202:5-6.
    PubMed     Text format    


  404. RUBBOLI A, Di Pasquale G
    Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal.
    Int J Cardiol. 2015;201:494-496.
    PubMed     Text format    


  405. CAY S, Ozcan F, Ozeke O, Aras D, et al
    Accessory pathway ablation in a patient with situs inversus totalis and Wolff-Parkinson-White electrocardiographic pattern: Mirror approach.
    Int J Cardiol. 2015;193:34-5.
    PubMed     Text format    


  406. RENILLA A, Rubin JM, Rozado J, Moris C, et al
    Long-term evolution of pacemaker dependency after percutaneous aortic valve implantation with the corevalve prosthesis.
    Int J Cardiol. 2015;201:61-63.
    PubMed     Text format    


  407. LIU F, Zhang Y, Zhang X, Guan G, et al
    Ventricular tachycardia with right bundle branch block morphology in arrhythmogenic right ventricular cardiomyopathy.
    Int J Cardiol. 2015;201:326-327.
    PubMed     Text format    


  408. MA W, Song X, Wang X, Zhong W, et al
    Catheter Ablation Resolves Ventricular Arrhythmias in a Patient with Sarcoidosis.
    Int J Cardiol. 2015;201:425-428.
    PubMed     Text format    


  409. CARPENTER A, Frontera A, Bond R, Duncan E, et al
    Vagal atrial fibrillation: What is it and should we treat it?
    Int J Cardiol. 2015;201:415-421.
    PubMed     Text format     Abstract available


  410. XIONG Q, Shantsila A, Lane DA, Zhou Q, et al
    Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: The Nanchang Atrial Fibrillation Project.
    Int J Cardiol. 2015;201:195-199.
    PubMed     Text format     Abstract available


  411. BLANN AD, Banerjee A, Lane DA, Torp-Pedersen C, et al
    Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.
    Int J Cardiol. 2015;201:693-698.
    PubMed     Text format     Abstract available


  412. PERRI L, Pastori D, Pignatelli P, Violi F, et al
    Reply to "The relation between flow mediated dilation and atrial fibrillation" by S. Balta: Refers to Sevket Balta, MD et al.
    Int J Cardiol. 2015;201:225-226.
    PubMed     Text format    


  413. UNLU M, Demirkol S, Yildirim AO, Balta S, et al
    Atrioventricular block associated with ticagrelor therapy may require permanent pacemaker.
    Int J Cardiol. 2015 Aug 7. pii: S0167-5273(15)30294.
    PubMed     Text format    


  414. TOMITA H, Okumura K, Inoue H, Atarashi H, et al
    Assessment of risk factors for bleeding in Japanese patients with non-valvular atrial fibrillation receiving warfarin treatment: A subanalysis of the J-RHYTHM Registry.
    Int J Cardiol. 2015;201:308-310.
    PubMed     Text format    


  415. KRON J, Ellenbogen K, Abbate A
    Recurrent ventricular fibrillation in a young female carrying a previously unidentified RyR2 gene mutation.
    Int J Cardiol. 2015;201:222-224.
    PubMed     Text format    


  416. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Int J Cardiol. 2015;201:513-516.
    PubMed     Text format     Abstract available


  417. ZAMBITO MP, Samuel BP, Vettukattil JJ, Ratnasamy C, et al
    Fluoroless catheter ablation of intraatrial reentrant tachycardia status post Fontan procedure: Fluoroless catheter ablation in Fontan patient.
    Int J Cardiol. 2015;201:126-128.
    PubMed     Text format    


    July 2015
  418. CHEN M, Yu L, Zhou X, Liu Q, et al
    Low-level vagus nerve stimulation: An important therapeutic option for atrial fibrillation treatment via modulating cardiac autonomic tone.
    Int J Cardiol. 2015;199:437-438.
    PubMed     Text format    


  419. KUKLIK P, Lau DH, Ganesan AN, Brooks AG, et al
    High-density mapping of atrial fibrillation in a chronic substrate: Evidence for distinct modes of repetitive wavefront propagation.
    Int J Cardiol. 2015;199:407-414.
    PubMed     Text format     Abstract available


  420. CAPODANNO D, Rossini R, Musumeci G, Lettieri C, et al
    Predictive accuracy of CHADS-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Int J Cardiol. 2015;199:319-325.
    PubMed     Text format     Abstract available


  421. BREMBILLA-PERROT B, Benichou M, Brembilla A, Bozec E, et al
    AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.
    Int J Cardiol. 2015;199:84-89.
    PubMed     Text format     Abstract available


  422. CHIALE PA, Baranchuk A, Gonzalez MD, Sanchez RA, et al
    The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
    Int J Cardiol. 2015;191:151-8.
    PubMed     Text format     Abstract available


  423. VAN MALDEREN SC, Kerkhove D, Theuns DA, Weytjens C, et al
    Prolonged right ventricular ejection delay identifies high risk patients and gender differences in Brugada syndrome.
    Int J Cardiol. 2015;191:90-6.
    PubMed     Text format     Abstract available


  424. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Int J Cardiol. 2015;199:248-252.
    PubMed     Text format     Abstract available


  425. LOSI MA, Izzo R, De Marco M, Canciello G, et al
    Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: The Campania Salute Network.
    Int J Cardiol. 2015;199:290-295.
    PubMed     Text format     Abstract available


  426. MASUDA M, Yamada T, Mizuno H, Minamiguchi H, et al
    Impact of atrial fibrillation ablation on cardiac sympathetic nervous system in patients with and without heart failure.
    Int J Cardiol. 2015;199:65-70.
    PubMed     Text format     Abstract available


  427. GUZZO-MERELLO G, Dominguez F, Gonzalez-Lopez E, Cobo-Marcos M, et al
    Malignant ventricular arrhythmias in alcoholic cardiomyopathy.
    Int J Cardiol. 2015;199:99-105.
    PubMed     Text format     Abstract available


  428. BALTA S, Aparci M, Yildirim AO, Demir M, et al
    The relation between flow mediated dilation and atrial fibrillation.
    Int J Cardiol. 2015 Jul 11. pii: S0167-5273(15)30154.
    PubMed     Text format    


  429. LIAO JN, Chao TF, Liu CJ, Wang KL, et al
    Risk and prediction of dementia in patients with atrial fibrillation - A nationwide population-based cohort study.
    Int J Cardiol. 2015;199:25-30.
    PubMed     Text format     Abstract available


  430. CHEN M, Yu L, Liu Q, Jiang H, et al
    Vagus nerve stimulation: A spear role or a shield role in atrial fibrillation?
    Int J Cardiol. 2015;198:115-116.
    PubMed     Text format    


  431. RAATIKAINEN MJ, Hakalahti A, Uusimaa P, Nielsen JC, et al
    Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
    Int J Cardiol. 2015;198:108-114.
    PubMed     Text format     Abstract available


  432. CHEN M, Yu L, Liu Q, Jiang H, et al
    Vitamin D: A potential important therapeutic target for atrial fibrillation.
    Int J Cardiol. 2015;198:91-92.
    PubMed     Text format    


  433. LETSAS KP, Efremidis M, Sideris A
    Gastroesophageal reflux disease and atrial fibrillation.
    Int J Cardiol. 2015;198:31.
    PubMed     Text format    


  434. SUZUKI H, Ohira T, Takeishi Y, Hosoya M, et al
    Increased prevalence of atrial fibrillation after the Great East Japan Earthquake: Results from the Fukushima Health Management Survey.
    Int J Cardiol. 2015;198:102-105.
    PubMed     Text format     Abstract available


  435. WASMER K, Unrath M, Kobe J, Malyar NM, et al
    Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease.
    Int J Cardiol. 2015;199:223-228.
    PubMed     Text format     Abstract available


  436. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
    P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
    Int J Cardiol. 2015;190:202-4.
    PubMed     Text format    


    June 2015
  437. GARCIA SEARA J, Gude F, Raposeiras-Roubin S, Martinez Sande JL, et al
    Long-term outcome prediction of CHADSVASc and HATCH scores in a cohort of patients with typical atrial flutter.
    Int J Cardiol. 2015;199:426-428.
    PubMed     Text format    


  438. HUANG B, Zhou X, Wang S, Zhou L, et al
    Renal sympathetic denervation: A potential therapeutic approach for long QT syndrome.
    Int J Cardiol. 2015;197:206-207.
    PubMed     Text format    


  439. HE B, Lu Z, He W, Jiang H, et al
    Autoantibodies against M-muscarinic and beta adrenergic receptors: New mediators in atrial fibrillation?
    Int J Cardiol. 2015;197:180-181.
    PubMed     Text format    


  440. LIN WY, Lin CS, Lin CL, Kao CH, et al
    Association of atrial fibrillation and erectile dysfunction: Reply.
    Int J Cardiol. 2015;197:166.
    PubMed     Text format    


  441. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
    Int J Cardiol. 2015;197:133-139.
    PubMed     Text format     Abstract available


  442. MATHIOUDAKIS AG, Mastoris I, Chatzimavridou-Grigoriadou V, Mathioudakis GA, et al
    The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide.
    Int J Cardiol. 2015;197:105-106.
    PubMed     Text format    


  443. RUBBOLI A, Agewall S, Huber K, Lip GY, et al
    New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Int J Cardiol. 2015;196:133-138.
    PubMed     Text format     Abstract available


  444. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  445. CARMO AA, Rocha MO, Silva JL, Ianni BM, et al
    Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease.
    Int J Cardiol. 2015;189:182-4.
    PubMed     Text format    


  446. TSAI WC, Lu YY, Chen YC, Chang CJ, et al
    Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
    Int J Cardiol. 2015;189:172-81.
    PubMed     Text format     Abstract available


  447. CHAN CS, Lin YJ, Chang SL, Lo LW, et al
    Early repolarization of surface ECG predicts fatal ventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and symptomatic ventricular arrhythmias.
    Int J Cardiol. 2015;197:300-305.
    PubMed     Text format     Abstract available


  448. PETERS S
    Electrocardiographic characteristics of arrhythmogenic right ventricular dysplasia, cardiac sarcoidosis and arrhythmogenic biventricular cardiomyopathy.
    Int J Cardiol. 2015;196:38-41.
    PubMed     Text format    


  449. LEE CH, Jang EJ, Kim DK
    Authors' reply to "The influence of autonomic nervous system on the conduction system and heart muscle. Do different inhaled bronchodilators cause different tachyarrhythmias?"
    Int J Cardiol. 2015;196:132.
    PubMed     Text format    


  450. LASEK-BAL A, Gasior Z, Kowalewska-Twardela T, Urbanek T, et al
    New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke.
    Int J Cardiol. 2015;195:210-211.
    PubMed     Text format    


  451. SHURRAB M, Newman D, Crystal E
    Empiric slow pathway ablation in suspected but not proven AVNRT: Reply to letter from Dr. Yetkin.
    Int J Cardiol. 2015;188:40.
    PubMed     Text format    


    May 2015
  452. CHUNG YW, Yang YH, Wu CK, Yu CC, et al
    Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
    Int J Cardiol. 2015 May 31. pii: S0167-5273(15)01271.
    PubMed     Text format     Abstract available


  453. CHAO TF, Liu CJ, Chen SJ, Wang KL, et al
    Statins and the risk of dementia in patients with atrial fibrillation: A nationwide population-based cohort study.
    Int J Cardiol. 2015;196:91-97.
    PubMed     Text format     Abstract available


  454. MUGNAI G, Irfan G, de Asmundis C, Ciconte G, et al
    Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients.
    Int J Cardiol. 2015;196:42-49.
    PubMed     Text format     Abstract available


  455. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Int J Cardiol. 2015;196:53.
    PubMed     Text format    


  456. BRAMBATTI M, Darius H, Oldgren J, Clemens A, et al
    Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Int J Cardiol. 2015;196:127-131.
    PubMed     Text format     Abstract available


  457. KALKAN K, Aksu U
    Association of atrial fibrillation and erectile dysfunction.
    Int J Cardiol. 2015;195:76.
    PubMed     Text format    


  458. AKSU U, Topcu S, Gulcu O, Kalkan K, et al
    Diastolic mitral and tricuspid regurgitation in a patient with 2:1 AV block.
    Int J Cardiol. 2015;195:111-112.
    PubMed     Text format    


  459. AL-RAWAHI M, Proietti R, Thanassoulis G
    Pericardial fat and atrial fibrillation: Epidemiology, mechanisms and interventions.
    Int J Cardiol. 2015;195:98-103.
    PubMed     Text format     Abstract available


  460. ANG R, Hunter RJ, Baker V, Richmond L, et al
    Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation.
    Int J Cardiol. 2015;195:253-258.
    PubMed     Text format     Abstract available


  461. XIONG Q, Chen S, Senoo K, Proietti M, et al
    The CHADS and CHADS-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
    Int J Cardiol. 2015;195:237-242.
    PubMed     Text format     Abstract available


  462. VAN DER WEG K, Kuijt WJ, Tijssen JG, Bekkers SC, et al
    Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI.
    Int J Cardiol. 2015;195:136-142.
    PubMed     Text format     Abstract available


  463. RAMUSCHKAT M, Appelbaum S, Atzler D, Zeller T, et al
    ADMA, subclinical changes and atrial fibrillation in the general population.
    Int J Cardiol. 2015;203:640-646.
    PubMed     Text format     Abstract available


  464. ZEB M, Curzen N, Allavatam V, Wilson D, et al
    Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool.
    Int J Cardiol. 2015;195:205-209.
    PubMed     Text format     Abstract available


  465. KIRAT T, Kose N, Altun I, Akin F, et al
    The influence of autonomic nervous system on the conduction system and heart muscle. Do different inhaled bronchodilators cause different tachyarrhythmias?
    Int J Cardiol. 2015;192:9-10.
    PubMed     Text format    


  466. XIONG Q, Proietti M, Senoo K, Lip GY, et al
    Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes.
    Int J Cardiol. 2015;191:172-177.
    PubMed     Text format     Abstract available


  467. KORANTZOPOULOS P, Liu T
    RDW as a marker of postoperative atrial fibrillation.
    Int J Cardiol. 2015;191:109.
    PubMed     Text format    


  468. LUZZA F, Crea P, Luzza G, Pugliatti P, et al
    Supernormal conduction in the left bundle branch block revealed by relatively late atrial extrasystoles.
    Int J Cardiol. 2015;191:117-119.
    PubMed     Text format    


  469. SANTARPIA G, Polimeni A, De Rosa S, Sabatino J, et al
    First case of subcutaneous implantable cardioverter-defibrillator extrusion.
    Int J Cardiol. 2015;192:19-20.
    PubMed     Text format    


  470. HURLEY C, Dai S, Sobieraj DM
    The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naive, new-onset nonvalvular atrial fibrillation.
    Int J Cardiol. 2015;192:1-2.
    PubMed     Text format    


    April 2015
  471. HARRELL DT, Ashihara T, Ishikawa T, Tominaga I, et al
    Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.
    Int J Cardiol. 2015;190:393-402.
    PubMed     Text format     Abstract available


  472. PETERS S
    Provocable coved-type ST-segment elevation in right precordial leads as initial ECG feature after successful resuscitation with developing arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;185:136-7.
    PubMed     Text format    


  473. ESPERER HD, Bajer M, Hahn J, Braun-Dullaeus RC, et al
    Effects of dronedarone on ventricular repolarization and repolarization dynamics in patients with preserved left ventricular systolic function.
    Int J Cardiol. 2015;185:119-21.
    PubMed     Text format    


  474. XI Y, Honeywell C, Zhang D, Schwartzentruber J, et al
    Whole exome sequencing identifies the TNNI3K gene as a cause of familial conduction system disease and congenital junctional ectopic tachycardia.
    Int J Cardiol. 2015;185:114-6.
    PubMed     Text format    


  475. CARBUCICCHIO C, Al Mohani G, Casella M, Pizzamiglio F, et al
    Uncommon ventricular tachycardia originating from an interventricular septal aneurism: Mapping and ablation guided by real-time image integration.
    Int J Cardiol. 2015;185:103-5.
    PubMed     Text format    


  476. OHLOW MA, von Korn H, Lauer B
    Characteristics and outcome of congenital left ventricular aneurysm and diverticulum: Analysis of 809 cases published since 1816.
    Int J Cardiol. 2015;185:34-45.
    PubMed     Text format     Abstract available


  477. CANPOLAT U
    Isolation of the Pandorra's box and end of the evils in left atrium.
    Int J Cardiol. 2015;185:7-8.
    PubMed     Text format    


  478. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  479. CHANG CJ, Cheng CC, Yang TF, Chen YC, et al
    Selective and non-selective non-steroidal anti-inflammatory drugs differentially regulate pulmonary vein and atrial arrhythmogenesis.
    Int J Cardiol. 2015;184:559-67.
    PubMed     Text format     Abstract available


  480. ZHANG E, Liu T, Li Z, Zhao J, et al
    High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
    Int J Cardiol. 2015;184:540-2.
    PubMed     Text format    


  481. DE MARIA GL, Pedersen M, Leo M, Bashir Y, et al
    Iatrogenic constrictive remodeling of left main stem after left coronary cusp atrial tachycardia ablation.
    Int J Cardiol. 2015;184:507-9.
    PubMed     Text format    


  482. TARUYA A, Tanaka A, Nishiguchi T, Iwaguro T, et al
    Necessity of magnetic resonance imaging examinations after permanent pacemaker implantation.
    Int J Cardiol. 2015;184:497-8.
    PubMed     Text format    


  483. GHAFOOR A, Janardhanan R
    Takotsubo cardiomyopathy: Utility of cardiac magnetic resonance to stratify risk for sudden cardiac death.
    Int J Cardiol. 2015;184:492-3.
    PubMed     Text format    


  484. EINDHOVEN JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, et al
    High-sensitive troponin-T in adult congenital heart disease.
    Int J Cardiol. 2015;184:405-11.
    PubMed     Text format     Abstract available


  485. MONTAIGNE D, Marechal X, Lacroix D, Staels B, et al
    From cardiac mitochondrial dysfunction to clinical arrhythmias.
    Int J Cardiol. 2015;184:597-9.
    PubMed     Text format    


  486. BRUNETTI ND, De Gennaro L, Santoro F, Guaricci AI, et al
    VT or not VT: That is the question.
    Int J Cardiol. 2015;184:391-3.
    PubMed     Text format    


  487. YETKIN E
    An extremely rare presentation of supraventricular tachycardia: Burping.
    Int J Cardiol. 2015;184:369-70.
    PubMed     Text format    


  488. KLIS M, Slawuta A, Gajek J
    Antiarrhythmic properties of atrial pacing - Alternative sites or better pharmacotherapy or both?
    Int J Cardiol. 2015;184:294-5.
    PubMed     Text format    


  489. HISAMATSU T, Miura K, Fujiyoshi A, Okamura T, et al
    Long-term outcomes associated with prolonged PR interval in the general Japanese population.
    Int J Cardiol. 2015;184:291-3.
    PubMed     Text format    


  490. ZUBERI Z, Jogiya R, Behr ER
    VERP in Brugada syndrome - Very effective risk predictor?
    Int J Cardiol. 2015;184:270-1.
    PubMed     Text format    


  491. SANTOS-PARDO I, Villuendas R, Salvador-Corres I, Martinez-Morillo M, et al
    Anti-Ro/SSA antibodies and cardiac rhythm disturbances: Present and future perspectives.
    Int J Cardiol. 2015;184:244-50.
    PubMed     Text format     Abstract available


    March 2015
  492. CHEN CH, Chen MC, Gibbs H, Kwon SU, et al
    Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.
    Int J Cardiol. 2015;191:244-253.
    PubMed     Text format     Abstract available


  493. NWAKILE C, Purushottam B, Bhalla V, Ukpong D, et al
    Significance of QRS duration in non-ST elevation myocardial infarction.
    Int J Cardiol. 2015;187:146-147.
    PubMed     Text format    


  494. AWAD S, Mohajer K, Baranchuk A, Pal RS, et al
    Current clinical practice of transesophageal echocardiography and cardiac computed tomography prior to atrial fibrillation ablation in Canada.
    Int J Cardiol. 2015;189:300-301.
    PubMed     Text format    


  495. WALTER C, Rottler E, von Wietersheim J, Cuntz U, et al
    QT-correction formulae and arrhythmogenic risk in female patients with anorexia nervosa.
    Int J Cardiol. 2015;187:302-303.
    PubMed     Text format    


  496. FRAGAKIS N, Antoniadis AP, Saviano M, Vassilikos V, et al
    The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives.
    Int J Cardiol. 2015;183:267-73.
    PubMed     Text format     Abstract available


  497. CALKOEN EE, Vicente-Steijn R, Hahurij ND, van Munsteren CJ, et al
    Abnormal sinoatrial node development resulting from disturbed vascular endothelial growth factor signaling.
    Int J Cardiol. 2015;183:249-57.
    PubMed     Text format     Abstract available


  498. UDO EO, van Hemel NM, Zuithoff NP, Doevendans PA, et al
    Risk of heart failure- and cardiac death gradually increases with more right ventricular pacing.
    Int J Cardiol. 2015;185:95-100.
    PubMed     Text format     Abstract available


  499. WONG CX, Lee SW, Gan SW, Mahajan R, et al
    Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2015;191:20-24.
    PubMed     Text format     Abstract available


  500. CIPRIANI M, Ammirati E, Landolina M, Oliva F, et al
    Cumulative analysis on 4802 patients confirming that women benefit more than men from cardiac resynchronization therapy.
    Int J Cardiol. 2015;182:454-6.
    PubMed     Text format    


  501. YETKIN E
    Documented but non-induced supraventricular tachycardia and vice versa.
    Int J Cardiol. 2015;182:438-9.
    PubMed     Text format    


  502. LAU YM, Hui WM, Lau CP
    Asystole complicating acalculous cholecystitis, the "Cope's sign" revisited.
    Int J Cardiol. 2015;182:447-8.
    PubMed     Text format    


  503. PINTO C, Samuel BP, Ratnasamy C, Vettukattil JJ, et al
    Thrombosis in Fontan patient on apixaban.
    Int J Cardiol. 2015;182:66-7.
    PubMed     Text format    


  504. PETERS S
    Is early sudden death in the course of arrhythmogenic cardiomyopathy due to initial Brugada syndrome?
    Int J Cardiol. 2015;182:107-8.
    PubMed     Text format    


  505. THONGPRAYOON C, Cheungpasitporn W, Srivali N, Kittanamongkolchai W, et al
    Incidence of acute kidney injury in reported cases of lead related cardiac perforation.
    Int J Cardiol. 2015;182:65.
    PubMed     Text format    


  506. SULTAN A, Luker J, Hoffmann B, Servatius H, et al
    Necessity of epicardial ablation for ventricular tachycardia after sequential endocardial approach.
    Int J Cardiol. 2015;182:56-61.
    PubMed     Text format     Abstract available


  507. YETKIN E, Kaleagzi FC
    Recovery of absence seizure-like symptoms in a patient after slow pathway radiofrequency ablation.
    Int J Cardiol. 2015;182:44-5.
    PubMed     Text format    


  508. ROSATO E, Gigante A, Liberatori M, Gasperini ML, et al
    QTc interval prolongation in systemic sclerosis: correlations with clinical variables.
    Int J Cardiol. 2015;182:20-2.
    PubMed     Text format    


  509. SANTORO F, Pellegrino PL, D'Arienzo G, Ziccardi L, et al
    "A cold shower": electrical magnetic interference caused by water heater current leakage through shower water pipe inducing ICD shock.
    Int J Cardiol. 2015;182:279-80.
    PubMed     Text format    


    February 2015
  510. ROSMAN L, Whited A, Lampert R, Mosesso VN, et al
    Cardiac anxiety after sudden cardiac arrest: Severity, predictors and clinical implications.
    Int J Cardiol. 2015;181:73-6.
    PubMed     Text format     Abstract available


  511. FRERE C, Laine M, Paganelli F, Dignat-George F, et al
    Antiplatelet properties of oral anticoagulants.
    Int J Cardiol. 2015;181:413-4.
    PubMed     Text format    


  512. BELL JR, Raaijmakers AJ, Curl CL, Reichelt ME, et al
    Cardiac CaMKIIdelta splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.
    Int J Cardiol. 2015;181:288-96.
    PubMed     Text format     Abstract available


  513. SENOO K, Lane DA, Lip GY
    Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Int J Cardiol. 2015;181:247-54.
    PubMed     Text format     Abstract available


  514. KORNEJ J, Hindricks G, Arya A, Sommer P, et al
    Presence and extent of coronary artery disease as predictor for AF recurrences after catheter ablation: The Leipzig Heart Center AF Ablation Registry.
    Int J Cardiol. 2015;181:188-92.
    PubMed     Text format     Abstract available


  515. FORD I, Robertson M, Komajda M, Bohm M, et al
    Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model.
    Int J Cardiol. 2015;184C:163-169.
    PubMed     Text format     Abstract available


  516. CHEUNG JW, Meli AC, Xie W, Mittal S, et al
    Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions.
    Int J Cardiol. 2015;180:228-36.
    PubMed     Text format     Abstract available


  517. MARQUEZ MF, Totomoch-Serra A, Burgoa JA, Mendez A, et al
    Abnormal electroencephalogram, epileptic seizures, structural congenital heart disease and aborted sudden cardiac death in Andersen-Tawil syndrome.
    Int J Cardiol. 2015;180:206-9.
    PubMed     Text format    


  518. CALVAGNA GM, Patane S
    Transvenous pacemaker lead extraction by femoral approach.
    Int J Cardiol. 2015;180:145-8.
    PubMed     Text format    


  519. ARROJA JD, Zimmermann M
    Phrenic nerve lesion: a potential complication of the nMARQ ablation technique.
    Int J Cardiol. 2015;180:91-2.
    PubMed     Text format    


  520. LIN CY, Chang SL, Lin YJ, Lo LW, et al
    Long-term outcome of multiform premature ventricular complexes in structurally normal heart.
    Int J Cardiol. 2015;180:80-5.
    PubMed     Text format     Abstract available


    January 2015
  521. JIN Q, Jacobsen PK, Pehrson S, Chen X, et al
    Acute and long term outcomes of catheter ablation using remote magnetic navigation for the treatment of electrical storm in patients with severe ischemic heart failure.
    Int J Cardiol. 2015;183C:11-16.
    PubMed     Text format     Abstract available


  522. HO LT, Lin LY, Yang YH, Wu CK, et al
    Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
    Int J Cardiol. 2015;201:538-543.
    PubMed     Text format     Abstract available


  523. BREMBILLA-PERROT B, Sellal JM, Olivier A, Manenti V, et al
    Recurrences of symptoms after AV node re-entrant tachycardia ablation: a clinical arrhythmia risk score to assess putative underlying cause.
    Int J Cardiol. 2015;179:292-6.
    PubMed     Text format     Abstract available


  524. GERBAY A, Vola M, Terreaux J, Steiner-Emptaz A, et al
    Resolution of stress induced reversible myocardial SPECT defect in Wolf Parkinson White (WPW) syndrome.
    Int J Cardiol. 2015;179:489-90.
    PubMed     Text format    


  525. HUANG B, Yu L, Jiang H
    A potential link between left stellate ganglion and renal sympathetic nerve: an important mechanism for cardiac arrhythmias?
    Int J Cardiol. 2015;179:123-4.
    PubMed     Text format    


  526. SHURRAB M, Szili-Torok T, Akca F, Tiong I, et al
    Empiric slow pathway ablation in non-inducible supraventricular tachycardia.
    Int J Cardiol. 2015;179:417-20.
    PubMed     Text format     Abstract available


  527. WONG CK
    Managing LBBB: Extracting full electrocardiographic information.
    Int J Cardiol. 2015;179:36-7.
    PubMed     Text format    


  528. RAPOSEIRAS-ROUBIN S, Garcia-Seara J, Cabanas-Grandio P, Abu-Assi E, et al
    Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
    Int J Cardiol. 2015;201:631-632.
    PubMed     Text format    


  529. HEIDENDAEL JF, Bokma JP, de Groot JR, Koolbergen DR, et al
    Weighing the risks: Thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease.
    Int J Cardiol. 2015;186:315-20.
    PubMed     Text format     Abstract available


  530. LIAO Z, Zhan X, Wu S
    Successful radiofrequency ablation of a parahisian accessory pathway from the right coronary cusp.
    Int J Cardiol. 2015;186:41-2.
    PubMed     Text format    


  531. DATTILO G, Scarano M, Casale M, Sergi M, et al
    An atypical manifestation of Twiddler syndrome.
    Int J Cardiol. 2015;186:1-2.
    PubMed     Text format    


  532. PETERS S
    Vectorcardiography: diagnostic advantage over electrocardiography in arrhythmogenic cardiomyopathy.
    Int J Cardiol. 2015;187:134-7.
    PubMed     Text format    


  533. GUPTA T, Khera S, Kolte D, Aronow WS, et al
    Antiarrhythmic properties of ranolazine: A review of the current evidence.
    Int J Cardiol. 2015;187:66-74.
    PubMed     Text format     Abstract available


  534. LAMBERTI F, Di Clemente F, Remoli R, Bellini C, et al
    Catheter ablation of idiopathic ventricular tachycardia without the use of fluoroscopy.
    Int J Cardiol. 2015;190:338-43.
    PubMed     Text format     Abstract available


  535. DILAVERIS P, Tsioufis C, Gatzoulis K, Tousoulis D, et al
    Extreme prolongation of sinus node recovery time in a coronary artery disease patient.
    Int J Cardiol. 2015;190:260-1.
    PubMed     Text format    


  536. LITTMANN L, Saxonhouse SJ
    Repetitive, incessant supraventricular tachycardia: Noninvasive determination of the electrophysiologic mechanism.
    Int J Cardiol. 2015;190:256-9.
    PubMed     Text format    


  537. LUO XX, Fang F, Yu CM
    Advantageous effect of biventricular pacing on cardiac function and coronary flow: A case report.
    Int J Cardiol. 2015;190:236-8.
    PubMed     Text format    


  538. ROMANO G, Raffa GM, Ruggieri A, Sgarito G, et al
    Recurrent ventricular tachycardia in a patient with continuous flow left ventricle assist device: Successful management with radiofrequency ablation and medical treatment.
    Int J Cardiol. 2015;190:198-200.
    PubMed     Text format    


  539. ENRIQUEZ A, Ali FS, Boles U, Michael K, et al
    Unipolar voltage threshold of 5.0 mV is optimal to localize critical isthmuses in post-infarction patients presenting with ventricular tachycardia.
    Int J Cardiol. 2015;187:438-42.
    PubMed     Text format     Abstract available


  540. TERNACLE J, Boiron P, Gallet R, Champagne S, et al
    Contribution of ultrasound contrast in predicting conduction disturbances during percutaneous alcohol septal ablation.
    Int J Cardiol. 2015;187:436-7.
    PubMed     Text format    


  541. SHIUE I
    Heart murmur and dysrhythmia are associated with accidents leading to poor mental health and cognition: Scottish Health Survey, 2013.
    Int J Cardiol. 2015;187:322-4.
    PubMed     Text format    


  542. LIU Z, Yu J, Fang PH, He J, et al
    Double device left atrial appendage closure with the WATCHMAN.
    Int J Cardiol. 2015;187:281-2.
    PubMed     Text format    


  543. IMRAN TF, Niazi OT, Amin R, Mazza V, et al
    Risperidone unmasking an accessory pathway.
    Int J Cardiol. 2015;187:488-90.
    PubMed     Text format    


    December 2014
  544. WONG GR, Lau DH, Baillie TJ, Middeldorp ME, et al
    Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation 'stiff left atrial syndrome'
    Int J Cardiol. 2014;181C:55-56.
    PubMed     Text format    


    November 2014
  545. GREVE AM, Bang CN, Berg RM, Egstrup K, et al
    Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: The SEAS study.
    Int J Cardiol. 2014;180C:122-128.
    PubMed     Text format     Abstract available


    October 2014
  546. KUWATA S, Yoneyama K, Koyama K, Saito M, et al
    A string-like red thrombus assessed by coronary angioscopy after using an aspiration catheter caused microvascular obstruction in a patient with ST-elevated myocardial infarction.
    Int J Cardiol. 2014 Oct 5. pii: S0167-5273(14)01871.
    PubMed     Text format    


    September 2014
  547. SCHNEIDER B, Athanasiadis A, Schwab J, Pistner W, et al
    Complications in the clinical course of tako-tsubo cardiomyopathy.
    Int J Cardiol. 2014;176:199-205.
    PubMed     Text format     Abstract available


  548. SQUARA F, Alonso C
    Unexceptional occurrence of tricky ECG findings in patients having new Biotronik ICDs.
    Int J Cardiol. 2014;176:262-3.
    PubMed     Text format    


  549. OZAWA K, Funabashi N, Takaoka H, Ueda M, et al
    Which number of morphological types of ventricular premature beats predicts poor prognosis in subjects with various cardiomyopathies without obstructed coronary arteries?
    Int J Cardiol. 2014;176:243-7.
    PubMed     Text format    


  550. HE J, Fang PH, Liu Z, Chen XB, et al
    Reversible tachycardia mediated cardiomyopathy after radiofrequency ablation of idiopathic left ventricular tachycardia.
    Int J Cardiol. 2014;176:e5-8.
    PubMed     Text format    


  551. CULIC V
    Inflammation, coagulation, weather and arrhythmogenesis: is there a linkage?
    Int J Cardiol. 2014;176:289-93.
    PubMed     Text format    


  552. TSAI WC, Lee TI, Chen YC, Kao YH, et al
    Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity.
    Int J Cardiol. 2014;176:110-8.
    PubMed     Text format     Abstract available


  553. OZAWA K, Funabashi N, Takaoka H, Ueda M, et al
    Risk stratification using a combination of left ventricular fibrosis and number of morphological types of ventricular premature beats in cardiomyopathy subjects without obstructed coronary arteries.
    Int J Cardiol. 2014;176:236-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: